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Abstract 
Proteins are the principal executive biomolecules of life. Their existence is required to drive and 
regulate countless physiological and biochemical activities within the cell. The study of biochemistry 
and biology are therefore frequently concerned with monitoring the presence, distribution, and function 
of proteins. Conventional protein identification assays are often labour-intensive and rely on the use of 
expensive antibodies. The development of new protein biosensors that incorporate nanotechnology, 
specifically gold nanoparticles (AuNPs), may allow for facile detection, identification, and 
quantification of proteins due to their colorimetric output. Unlike other strategies that use antibody-
functionalized gold nanoparticles, the pairing of non-functionalized nanoparticles with spectroscopic 
analysis may further reduce the cost of analysis and make this technology viable for consumer-level 
applications. 
This thesis focuses on the development of a gold nanoparticle biosensor for the detection, 
identification, and quantification of proteins. The underlying principle is based on the aggregation of 
non-functionalized gold nanoparticles in the presence of proteins. The physicochemical characteristics 
of these gold nanoparticles can be manipulated to alter their response to different proteins. In order to 
achieve identification based on non-specific interactions, a “chemical nose” strategy is followed, 
whereby different gold-nanoparticles produce different individual responses, and their collective 
response defines a unique signature for a given protein. A review of current literature presents the 
variety of biological, chemical, and physical factors that can affect protein-nanoparticle interactions, 
and their resultant effect on colloidal stability. This review also highlights the complexity with which 
these factors can interact and identifies key considerations for maintaining or controlling colloidal 
stability in various applications.  
The experiments herein address the role of shape and surfactant-type on aggregation of gold 
nanoparticles. Shape has previously been shown to affect protein-nanoparticle interactions, but to our 
knowledge has not been exploited for protein sensing applications. The role of surfactant on protein-
gold nanoparticle interactions is not well studied and provides a novel avenue for investigation. This 
work demonstrates that both these parameters can be used to alter protein-nanoparticle interactions, 
thereby permitting “chemical nose”-type detection of proteins. Overall, these studies highlight how 
modifying protein-nanoparticle interactions can be used for the benefit of biosensing in research and 
clinical settings. In addition to biosensing, this manner of investigation can serve as a powerful tool to 
study protein-nanoparticle interactions, with widespread implications in medicine, environmental 
protection, and water treatment.  
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Chapter 1 
Introduction 
1.1 Overview 
Proteins play an integral role in countless biochemical processes. Among their roles, they can act as 
biological catalysts, signalling molecules, or structural components. As such, many clinical tests aim to 
identify, quantify, or measure the activity of proteins. For instance, high serological levels of tissue 
transglutaminase antibody (tTG-IgA) are indicative of celiac disease
1
, and elevated levels of 
immunoglobulin G antibodies (IgG) can be used to diagnose autoimmune hepatitis
2
. The ability to 
reliably detect and quantify proteins is a key part of life science research. 
Many conventional protein assays, such as enzyme-linked immunosorbent assay (ELISA), require 
skilled operators and sensitive antibody reagents. Recent developments in gold nanoparticle-based 
assays promise not only to simplify this process, but also to improve assay sensitivity and adaptability.
3
 
Nanoparticles are advantageous for many sensing platforms due to their unique properties including a 
high surface area-to-volume ratio. Gold nanoparticles in particular also possess unique optical 
properties. Due to localized surface plasmon resonance (LSPR), the aggregation of gold nanoparticles 
in solution results in a visible colour change
4
. This allows users to easily track changes in nanoparticle 
aggregation, which is beneficial for many sensing platforms. By designing gold nanoparticles that 
change their colour in response to a particular protein or analyte, users can easily read these 
colorimetric sensors without specialized equipment. 
One common strategy for detecting biomolecules with gold nanoparticles is to use nanoparticles 
with surface-functionalized probes.
5–8
 These probes, often antibodies or aptamers, can then interact with 
proteins in solution to aggregate or stabilize the gold nanoparticles. Given that functionalization of gold 
surfaces is well studied, this method provides convenient detection of proteins with good specificity. 
However, production of probe-functionalized gold nanoparticles may be limited by the requirement for 
specific antibodies, which increase assay cost. Furthermore, antibodies may be sensitive to temperature 
and pH fluctuations that could hinder their performance and present challenges for consumer-level 
deployment. 
The observation that proteins can induce aggregation of non-functionalized gold nanoparticles has 
led several groups to investigate the use of probeless nanoparticles for colorimetric protein sensing.
9–11
 
Unlike probe-functionalized nanoparticles, these nanoparticles change their colloidal stability in 
2 
 
response to many different proteins. Variations in amino acid composition
12
, protein identity
13,14
, and 
protein structure
11
 generate a unique response from protein to protein. In order to maximize differences 
in protein-nanoparticle interaction, it can be beneficial to use a variety of different nanoparticles, where 
each nanoparticle responds differently to a given protein. This type of biosensors, which relies on an 
array of responses instead of a single output, has been called a “chemical nose”.15 The array of 
responses allows for greater discrimination between samples when compared to a single output, and 
harnessing these differences could lead to the development of low-cost broad-spectrum protein sensors. 
1.2 Research objectives 
The aim of the following project is to investigate the application of non-functionalized gold 
nanoparticles for “chemical nose” colorimetric detection of proteins. In order to enhance discrimination 
between proteins, variations in nanoparticle structure, surface properties, and their effect on colloidal 
stability with proteins is explored. The potential for certain properties to alter protein-nanoparticle 
interactions was first established from literature review. Based on these findings, the following 
objectives were established: 
1. Demonstrate that cetyltrimethylammonium bromide (CTAB)-coated morphologically-
controlled gold nanoparticles produce a colorimetric response in the presence of protein. 
a. Investigate whether the observed response is dependent on protein concentration to 
evaluate the potential for protein quantification 
b. Investigate whether spherical and branched gold nanoparticles generate different 
responses to an array of proteins to evaluate the potential for “chemical nose” type 
array sensing 
 
2. Establish the potential for “chemical nose” protein sensing in complex mixtures 
a. Investigate the possibility of identifying protein mixtures based on the response of 
single proteins 
b. Determine the ability to detect variations in protein concentration in the complex 
environment of human serum 
 
3. Develop gold nanoparticles with different surface properties by controlling the presence of 
surfactants. 
a. Determine whether replacing cationic surfactants with non-ionic or anionic 
surfactants can change particle surface charge 
3 
 
b. Determine whether changing the stabilizing surfactant affects the colloidal stability 
of gold nanoparticles 
 
4. Expand the capabilities of the “chemical nose” protein biosensor by including surfactant-
modified gold nanoparticles 
a. Observe whether changing the stabilizing surfactant alters a nanoparticle’s 
colloidal response to protein 
b. Determine whether protein discrimination is improved with a three-surfactant array 
c. Investigate the effect of surfactant concentration on protein-induced nanoparticle 
aggregation 
1.3 Thesis outline 
This thesis is comprised of five sections including one general introduction to the research topic, 
one section of literature review, two sections of experimental research, and a conclusion which 
summarizes the work and provides future outlooks. 
Chapter 1 provides an overview of the research topic and questions which will be addressed 
through literature review and/or experimental approaches. This section also helps outline the framework 
of the thesis. 
Chapter 2 consists of a literature review on the subject of gold nanoparticle-protein interactions, 
their effects on colloidal stability of gold nanoparticles, and the significance of these interactions on 
various nanotechnology applications. Given the vast potential for gold nanoparticles to improve 
biosensing, diagnostic, and treatment applications in clinical and research settings, their interactions 
with proteins have come under considerable investigation in recent years. However, as is shown in this 
review, the complex interactions between biological, chemical, and physical factors can lead to debate 
as to their effects on colloidal stability. Here, we compile current research, identify key aspects of 
protein-nanoparticle interactions, and discuss their potential interactions. In doing so, we seek not only 
to help in interpreting conflicting results, but also to identify new avenues of investigation. 
Chapter 3 presents the first development of a gold nanoparticle “chemical nose” sensor capable of 
identifying and quantifying proteins in solution. Here, we leverage the impact of gold nanoparticle 
morphology on protein-nanoparticle interactions. By mixing various protein solutions with spherical 
and branched gold nanoparticles, we observe differences in colloidal stability that are sensitive to both 
protein concentration and identity. This technique is also used to distinguish between various protein 
4 
 
mixtures and complex media, supporting possible applications for clinical and diagnostic applications. 
These experiments lay the foundation for this protein sensing “chemical nose” technique. 
Chapter 4 expands on previous “chemical nose” techniques by investigating the role of surfactant 
on colloidal stability of gold nanoparticle-protein solutions. We first observe that altering the surfactant 
in which gold nanoparticles are stabilized can be achieved using a facile surfactant replacement 
procedure. Critically, we established that changes in surfactant can radically alter the aggregation 
response of gold nanoparticles to proteins. To our knowledge, this is the first time this relationship 
between stabilizing surfactant and protein-gold nanoparticle interactions has been investigated and the 
findings stand to significantly affect the development of future nanoparticle systems. 
Finally, chapter 5 provides a summary of conducted research and experiments which comprise this 
thesis and key conclusions which can be drawn from our findings. We also identify future directions for 
improving this technology and expanding the application of gold nanoparticles for protein sensing and 
identification. 
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Chapter 2 
Literature Review 
2.1 Summary 
Gold nanoparticles are among the most popular materials in nanobiotechnology. Their unique 
optical properties, facile surface functionalization, and biocompatibility make them a versatile platform 
for sensing, diagnostic, and therapeutic applications. In many cases, controlling the colloidal stability of 
gold nanoparticles is vital for optimal performance. Particles which aggregate too readily or do not 
aggregate when needed are both examples of undesirable behavior. While specific interactions between 
proteins and functionalized antibodies or aptamers are commonly used to stabilize or aggregate gold 
nanoparticles, it has been known for some time that proteins can adsorb non-specifically to gold 
nanoparticles, thereby inducing changes in their colloidal stability. Unfortunately, this aspect is often 
overlooked when discussing their application. Given the ubiquitous nature of proteins in biological 
samples, this represents a significant gap in the development of reliable gold nanoparticle systems. 
While recent investigations have started to identify factors affecting protein-gold nanoparticle 
interactions, the multitude of factors and variations between studies makes interpretation of findings 
difficult. Here, we review the effect of non-specific protein-nanoparticle interactions on colloidal 
stability of gold nanoparticles. First, we provide an overview of physicochemical factors which can 
affect protein-gold interactions. Then we discuss recent studies into their effect on nanoparticle 
aggregation and stability. Finally, we put these factors in context with several examples of sensing, 
diagnostic, and therapeutic applications which are heavily influenced by these effects. Understanding 
how proteins can affect the colloidal stability of gold nanoparticles is an important aspect for 
developing reliable applications. 
2.2 Introduction 
Gold nanoparticles have experienced a dramatic increase in popularity over the past several years as 
researchers aim to harness their unique physical and chemical properties for a wide range of sensing, 
diagnostic, and therapeutic applications. These metallic nanoparticles exhibit several attractive 
characteristics which make them especially promising for life science research. Among these 
characteristics are large surface areas with well known methods for molecule attachment
16
, relatively 
low cytotoxicity and good biocompatibility
17
, well characterized synthesis procedures capable of 
controlling nanoparticle morphology
18
, and unique optical properties which facilitate analysis
4,19
. 
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The ability to control nanoparticle aggregation is central to many applications.
20
 In certain 
scenarios, such as cellular uptake and catalysis, aggregation of gold nanoparticles is undesirable since it 
can alter their behavior and reduce available surface area. In other scenarios, controlled aggregation in 
response to biological, chemical, or physical cues is desirable as a method of colorimetric detection.
20
 
Regardless of the particular application, careful consideration must be given to the colloidal stability of 
gold nanoparticles to ensure they maintain their desired function. 
While specific interactions between probe-functionalized gold nanoparticles and their respective 
proteins are comparatively easy to predict and extensively studied, the study of non-specific 
interactions between proteins and gold nanoparticles is just starting to increase in popularity. These 
interactions are often unplanned and exist as a consequence of having proteins in solution. It is well 
known that non-specific interactions between a variety of materials and proteins modulate both the 
physical characteristics and behavior of nanoparticles.
21
 The ubiquitous nature of proteins in biological 
media means that gold nanoparticles in biological samples will almost certainly be influenced by one or 
more proteins. While recent years have produced a substantial body of evidence linking the interaction 
of proteins and gold nanoparticles to colloidal stability, the absence of systematic investigations means 
that effects must be interpreted on a case by case basis. Furthermore, it is not uncommon for similar 
studies to reach conflicting conclusions based on slight variations in experimental detail. A prominent 
example is the ability of certain proteins to both stabilize
9,22
, and aggregate
11,23
 similar gold 
nanoparticles. These findings are likely dependent on many experimental factors which were not the 
primary focus of the study (e.g. ionic strength, particle morphology, protein conformation). 
Understanding the potential interference of these factors is a necessary step in drawing useful 
conclusions. 
The non-specific adsorption of proteins on the gold nanoparticle surface is often part of the putative 
mechanism for particle aggregation or stabilization. As such, much of this review is also concerned 
with protein adsorption on nanoparticle surfaces. The adsorbed protein layer is commonly referred to as 
the “protein corona” and contributes largely to defining the nanoparticle’s “biological identity” as well 
as its physical characteristics. Three major phenomena that play key roles in protein corona formation 
are thiol-gold bonding
12,24
, hydrophobic bonding
22
, and electrostatic interactions
25
. Given the intimate 
connections between different experimental conditions that affect these phenomena, it is impossible to 
discuss them in isolation. However, for the purpose of this review, they can be roughly grouped into 
two themes: charge and structure. Charge factors such as particle zeta potential and protein isoelectric 
point have long been used to explain protein-nanoparticle interactions, while the importance of 
structure-based factors such as particle morphology and protein conformation have only recently gained 
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attention. The environment in which proteins interact with nanoparticles has been shown to play a 
crucial role in determining nanoparticle stability
26–28
, therefore factors such as ionic strength
29
, 
surfactants
30
, pH
31,32
, and temperature
33
 cannot be overlooked. 
This complexity of protein-nanoparticle interactions has led some to claim that general laws for 
protein adsorption are unlikely to exist.
34
 Yet, the ability to predict and control colloidal stability of 
gold nanoparticles in the presence of proteins is invaluable in the pursuit of novel applications. Herein 
we will outline several key factors identified in recent studies on protein-gold nanoparticle interactions 
as well as their potential effects on gold nanoparticle stability. We will also discuss some practical 
considerations concerning the performance of sensing, diagnostic, and therapeutic assays based on gold 
nanoparticles. 
2.3 Factors affecting protein-gold nanoparticle interactions 
2.3.1 Charge 
Electrostatic forces are often cited as the most influential factor in protein adsorption and 
nanoparticle stability. A zeta potential of ± 30 mV is typically considered sufficient to prevent 
nanoparticles in aqueous solution from aggregating due to electrostatic repulsion. The magnitude of the 
electrostatic force (Fe) between two electrically charged particles is described in its simplest form by 
Coulomb’s law, 
          
    
  
   (Eq. 2.1) 
where q1 and q2 are the point charges of two particles, r is the separation distance, and ke is Coulomb’s 
constant (~8.99 x 10
9
 Nm
2
C
-2
). The magnitude of this interaction force is therefore proportional to the 
charges q1 and q2, and is inversely proportional to the square of the separation distance. If the product of 
q1 and q2 is positive, Fe > 0 and the force is repulsive. If the product is negative, Fe < 0, and the force is 
attractive. Based on this model, electrostatic forces between like charged nanoparticles will contribute a 
repulsive force, stabilizing the colloid. In reality, the presence of ions in aqueous media leads to the 
formation of an electrostatic double layer, resulting in a screened-Coulomb interaction which can 
reduce stability.
35–37
 Furthermore, van der Waals (VDW) forces also modulate interaction of particles in 
solution.
37,38
 The summative effect of these forces on colloidal stability is often approximated using the 
familiar Derjaguin-Landau-Verwey-Overbeek (DLVO) theory.  
Similarly, the strength and direction of electrostatic force between proteins and nanoparticles 
depends on the net charge and charge distribution of both bodies. Unless the gold nanoparticle surface 
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is completely bare, its surface charge will be largely dependent on the nature of adsorbed monolayers or 
stabilizing agents. Common methods for stabilizing gold nanoparticles include citrate ions, ionic and 
non-ionic surfactants, and polymeric coatings (e.g. poly(ethylene glycol)(PEG), poly(acrylic 
acid)(PAA), poly(allylamine hydrochloride)(PAH)). Depending on which method is used, nanoparticles 
can have negative, neutral, or positive surface charges which govern their electrostatic behavior. 
Several studies report electrostatic attraction to be the primary mechanism for adsorption of charged 
proteins on oppositely charged gold nanoparticles.
10,39
 Unlike thiol-gold and van der Waals interactions 
which are relatively short-ranged effects that contribute strongly to adhesion near the gold surface, the 
long-range nature of electrostatic forces could facilitate transport of proteins towards the surface.
37
 
Nevertheless, adsorption is sometimes reported for like-charged proteins and nanoparticles
40
, indicating 
that opposite charge is not a requirement. 
2.3.1.1 pH 
The charge of amino acids, like other amphiprotic molecules, is sensitive to environmental 
conditions due to the loss or gain of protons. The protonation state of any single amino acid residue is a 
function of pH and the acid dissociation constant (pKa) for its functional group. The net charge of a 
protein is determined by the ratio of positively and negatively charged functional groups. The 
isoelectric point (pI) of a protein is the pH at which charges are balanced and the protein adopts a 
neutral charge. Increasing the pH above the pI will lower the concentration of protons and promote 
deprotonation of amino acid residues, resulting in negatively charged proteins. Conversely, lowering 
the pH below the pI will promote protonation and yield positively charged proteins. As such, the net 
charge of a protein depends largely on its amino acid sequence and the solution pH. 
Given that electrostatic charge is one of the primary factors that drive protein-gold nanoparticle 
interactions, it is not surprising that changing the solution pH can affect protein adsorption. A study 
proposing the application of citrate-capped gold nanoparticles for detection of urinary lysozyme (Lyz) 
has shown that the amount of gold nanoparticle aggregation is sensitive to solution pH.
10
 At pH 7, 
lysozyme carries a net positive charge (pI = 11) and induces aggregation of negatively charged gold 
nanoparticles. Incremental increases in pH between 3 and 11 resulted in decreased nanoparticle 
aggregation as monitored by plasmon resonant light scattering (PRLS).
10
 This aggregation was not 
simply due to a decrease in nanoparticle stability at low pH since no variations in PRLS were observed 
in the absence of lysozyme. Furthermore, at a pH of 10 and 11, the PRLS of gold nanoparticles with 
lysozyme was comparable to those without the protein, which suggests that neutrally charged lysozyme 
does not induce aggregation of anionic citrate-capped gold nanoparticles. This pH-dependent 
9 
 
electrostatic adsorption model is consistent with studies by Pan et al. which noted that adsorption rate 
constants between Protein G B1 domain (GB1) and negatively charged latex particles were highest 
when solution pH conferred a strong net positive charge to GB1.
41
 
Since gold nanoparticle-protein solutions appear to aggregate more readily when proteins and 
nanoparticles are oppositely charged, it is possible that changes in protein identity, amino acid 
sequence, and post-translational modifications can affect whether aggregation is observed. Using 
chemical modification of amino acids in three proteins with different pIs, one group has confirmed that 
changes in protein charge affect whether they caused aggregation of gold nanoparticles.
39
 In this study, 
lysozyme, α-lactalbumin, and myoglobin were modified either by succinylation, acetylation, or 
aminoalkylation to change the charge on particular residues. Upon incubation with negatively charged 
gold nanoparticles, aggregation was only observed when proteins were positively charged (at pH values 
lower than the new pI of the modified protein). These findings support the idea that gold nanoparticle 
stability in the presence of proteins is highly dependent on solution pH. 
Variations in pH can also affect the surface charge of nanoparticles coated with organic molecules. 
If gold nanoparticles are functionalized with amphiprotic peptides or PEG, their colloidal stability can 
be affected by charge neutralization.
27
 Here, neutralization of carboxylic acid groups at pH < 5 was 
shown to cause nanoparticle aggregation when the electrostatic repulsive force was decreased. 
10 
 
 
Figure 2.1 pH dependent lysozyme charge and aggregation of citrate-capped gold nanoparticles. 
Adapted from Yu et al. 2015
42
, and Wang et al. 2010
10
. 
2.3.1.2 Ionic Strength 
It is generally well known that gold nanoparticle suspensions can be induced to aggregate under 
conditions of high ionic strength.
7,35,43,44
 As an example, Pamies et al.
35
 observed that addition of 75 
mM sodium nitrate salts to suspensions of citrate-stabilized gold nanoparticles was sufficient to induce 
the formation of aggregates. The overall colloidal stability was inversely proportional to ionic 
strength.
35
 This relationship between ionic strength and colloidal stability is by no means exclusive to 
gold nanoparticles, as similar behavior has been characterized in other materials such as silver
45,46
, 
polystyrene
47
, and numerous metal oxides
48–50
. 
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The influence of ionic strength on protein-gold nanoparticle binding experiments is often 
overlooked or not reported, despite evidence showing that ionic strength can influence the adsorption of 
proteins onto gold surfaces. One study found that binding constants for bovine serum albumin (BSA) 
on gold nanorods were different in MOPS buffer and pure water.
51
 A study on negatively charged latex 
particles suggests similar dependence between GB1 adsorption and ionic strength where varying NaCl 
concentration from 70 mM to 200 mM caused a significant decrease in association rate.
41
 These 
findings are consistent with the common model for charge-screened interactions, whereby electrostatic 
forces between charged bodies are reduced by electrostatic double layer formation. These changes in 
protein adsorbance can ultimately affect the stability of gold nanoparticles by altering corona thickness, 
surface coverage, and corona composition when proteins have different pIs. 
Adsorption of biomolecules is sometimes used to prevent aggregation of nanoparticles under high 
salt concentrations.
45,46,52
 For proteins, this is often explained by the formation of a protein corona 
which provides steric stability when high salt concentrations screen electrostatic repulsion.
53
 Since 
steric stabilization by surface-attached polymers such as PEG produces nanoparticles which are already 
stable under high ionic strength
54,55
, this effect is presumably greatest for those charged nanoparticles 
which rely predominantly on electrostatic repulsion. 
In addition to the inherent destabilizing effect of certain ions and their effect on protein adsorption, 
salts can alter long-distance interactions between non-adsorbed proteins and nanoparticles. One group 
that observed BSA contributing to depletion-aggregation of gold nanoparticles decorated with ethylene 
glycol noted that addition of 0.3M NaCl increased the rate of nanoparticle aggregation and decreased 
the critical protein concentration necessary to cause aggregation.
38
 In this case, the presence of ions was 
thought to screen the surface charge of proteins and enhance the depletion effect. Further studies by the 
same group confirmed that electrostatic repulsion presents a significant energy barrier to nanoparticle 
aggregation at low salt concentrations, and that charge screening at high salt concentrations makes 
particles aggregate faster in a diffusion-limited process.
56
 
2.3.2 Structure 
2.3.2.1 Nanoparticle morphology 
Gold nanoparticles can be synthesized in a variety of different sizes and shapes. Due to localized 
surface plasmon resonance, shape and size affects the electromagnetic absorbance spectrum of gold 
colloids. For example, larger particles usually exhibit absorbance peaks at longer wavelengths.
57–59
 
Aggregation of gold nanoparticles can also cause a red-shift in their absorbance spectrum.
4
 This 
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property is commonly used for colorimetric sensing applications to produce nanoparticle solutions with 
different colours where colour change reflects particle size or aggregation state. Along with size 
control, varying shape anisotropy is a common method for modifying the optical and physical 
characteristics of gold nanoparticle suspensions.
59
 Cubic
60–62
, pyramidal
60,62,63
, rod-shaped
60,62–64
, and 
branched gold nanoparticles
60,62,65,66
, have all been reported in literature, and shape has a direct effect on 
the absorbance spectrum
59
. For example, gold nanorods with higher or lower aspect ratios can be 
synthesized using seed-mediated growth in the presence of a template surfactant.
60
 The resultant 
particles exhibit two LSPR peaks reflecting the longitudinal and transverse dimensions of the rod.
30,67
 In 
addition to varying optical characteristics, the variety of particle sizes and shapes may also affect how 
particles interact with adsorbed proteins and their resultant colloidal stability. As such, it is important to 
acknowledge that nanoparticle morphology can affect their behavior in biological media. 
Cytochrome c was found to prevent salt-induced aggregation of citrate-stabilized gold nanoparticles 
between 2 nm and 41 nm in diameter.
68
 However, stability was only observed when the number of 
cytochrome c molecules per nanoparticle exceeded a certain size-dependent threshold. Larger 
nanoparticles required more cytochrome c molecules to become stabilized than smaller nanoparticles. 
Jiang et al.
68
 also concluded that electrostatic forces dominate the adsorption mechanism of cytochrome 
c onto 16 nm particles, while hydrophobic forces dominate on smaller 2-4 nm particles, based on the 
observed ratio of α-helix and random coil structure as well as the position of a positively charged grove 
rich in lysine. In surveying an array of common human blood proteins (i.e. γ-globulin, fibrinogen (Fib), 
insulin, human serum albumin (HSA), and histone) and their interactions with citrate-stabilized gold 
nanoparticles, de Paoli et al.
69
 also observed the size-dependent formation of protein coronas and 
protein-nanoparticle aggregates. As particle size increased from 5 nm to 60 nm, a general increasing 
trend in association constant between each protein and the nanoparticle surface was observed. Above 60 
nm, the trend continued for globulins and insulin, while albumin, fibrinogen, and histone association 
constants remained approximately the same or decreased slightly. This increase in association constants 
was associated with an increase in protein corona thickness. A similar study investigating the role of 
PEG grafting density and nanoparticle size (15-90 nm) on adsorption density of serum proteins found 
that protein density was higher on smaller particles, presumably owing to reduced steric interaction on 
highly curved surfaces.
70
 This relationship between density of protein coverage and particle size is 
especially important for colloidal stability of nanoparticles in cases where aggregation is believed to be 
caused by bridging flocculation, such as in the case of fibrinogen binding to poly(acrylic acid) coated 
gold nanoparticles
71
. Here, it was proposed that fibrinogen can induce aggregation of gold nanoparticles 
large enough to bind multiple protein molecules. Size of gold nanoparticles can also affect their 
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colloidal stability when particles are protected from protein adsorption. As previously mentioned, when 
gold nanoparticles of various sizes were decorated with ethylene glycol and incubated with BSA, 
depletion aggregation was found to drive aggregate formation.
38
 In addition to the charge-screening 
effect, the authors also noted that the critical protein concentration required to induce aggregation was 
much higher for small nanoparticles, and proposed that large particles experience higher osmotic 
pressures which drive them together. 
While some studies have sought to characterize how nanoparticle shape influences protein 
adsorption, the role of particle shape in protein-induced aggregation remains poorly understood. A 
common theme among studies is the role of nanoparticle shape in changing protein conformation. This 
relationship was demonstrated by incubating positively charged lysozyme and α-chymotrypsin with 
negatively charged (16-mercaptohexadecanoic acid-stabilized) spherical and rod-shaped gold 
nanoparticles.
14
 While the number of adsorbed proteins per spherical particle was similar for lysozyme 
and α-chymotrypsin, both proteins adhered in greater numbers to rod-shaped proteins. Particle surface 
area was noted as a potential reason for this difference; however the three-fold increase in surface area 
is appreciably lower than the change in protein density which increased more than eight-fold. Also, 
while both proteins were similar in molecular weight and dimensions, their adsorption and 
conformational changes differed.
14
 The authors attributed these differences to variations in secondary 
structure and isoelectric point, highlighting the importance of protein identity on nanoparticle 
aggregation. It was proposed that nanoparticle aggregation occurs due to the binding interaction of 
structurally altered proteins on adjacent nanoparticles. Aggregation is therefore determined by the 
propensity of a particular protein identity to change its conformation upon adsorption to a gold surface, 
and this propensity is influenced by nanoparticle shape. Thick protein coronas may result in stable 
particles if underlying proteins shield the outermost layer from the denaturing effects of the gold 
surface.
14
 
A similar investigation into BSA interactions with spherical and rod-shaped 
cetyltrimethylammonium bromide (CTAB)-coated gold nanoparticles revealed that BSA underwent a 
conformational change and loss of function upon binding to rod-shaped particles. This denaturation was 
not observed with spherical particles 
33
. However, the LSPR absorbance peaks for both particle shapes 
exhibited broadening characteristic of gold nanoparticle aggregation. When comparing the effect of 
three similarly sized nanoparticles of different shapes (spheres, rods, and triangles) on BSA adsorption, 
Chaudhary et al.
40
 observed that BSA bound most strongly to spherical gold nanoparticles, followed by 
rod shaped, and finally triangular particles. Interestingly, the authors did not identify any nanoparticle 
aggregation, regardless of particle shape or protein denaturation. Together, these findings suggest not 
14 
 
only that gold nanoparticle shape is an important factor in protein adsorption, protein denaturation, and 
colloidal stability, but also that loss of protein conformation is neither sufficient nor required for 
aggregate formation. 
 
2.3.2.2 Protein conformation and composition 
It is clear that interactions between gold nanoparticles and proteins are highly dependent on the 
identity of the protein. Several studies observed differences in protein adsorption and resultant 
nanoparticle aggregation when assaying different proteins.
11,13,14
 These differences are not surprising 
given the diversity of proteins with respect to size, shape, chemical composition, charge and 
hydrophobicity. The primary structure of a protein is defined by its sequence of amino acids and their 
corresponding functional groups. Whether these groups are exposed and accessible for direct interaction 
(e.g. with the gold surface) is determined by secondary, tertiary, and quaternary structure. Since 
changes in protein conformation can rearrange these features and change the physicochemical nature of 
the protein surface, conformation likely plays a key role in protein-nanoparticle interactions that can 
lead to stability or aggregation of gold colloids. 
The strong bonding interaction between the sulfur atom of thiol groups (-SH) and gold surfaces is a 
popular tool in the preparation of self-assembled monolayers. Cysteine is the only naturally occurring 
amino acid which contains a thiol group. As such, several studies into protein-gold interactions have 
investigated the role of cysteine residues in protein adsorption and nanoparticle aggregation.
11,12,24,72
 
Generally, cysteine residues are believed to contribute most strongly when they are accessible at the 
protein surface and not buried within the core of globular proteins or occupied in disulfide bonds. A 
recent study by Thioune et al.
72
 investigated the degree of interaction between gold nanorods and four 
different globular proteins by monitoring changes in the LSPR characteristic of nanoparticle 
aggregation. They found that the number of solvent-accessible thiol groups per protein is a contributing 
factor in the observed LSPR shift. It was also proposed that their spatial distribution on the exposed 
surface is critical since neighbouring cysteine residues can behave as one due to steric accessibility and 
exposed cysteines on opposite sides of the protein could potentially bridge two nanoparticles, thus 
forming strong aggregates. While some studies have found that presence of cysteines does not 
contribute strongly to initial adsorption of proteins, it is generally accepted that they solidify the 
attachment and contribute to irreversible “hard” corona formation12,24. Siriwardana et al.12 demonstrated 
this effect by bioengineering Protein G B3 domain (GB3) to contain 0, 1, or 2 cysteine residues. While 
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the absence of cysteine had no effect on binding kinetics, GB3 without cysteine was readily displaced 
from the nanoparticle surface, unlike variants with 1 or 2 cysteines. 
Amine groups are also capable of strong bonding to gold. Primary amines in particular have been 
shown to bind strongly to gold crystals.
73
 When incorporated into a polypeptide chain, four amino acids 
(arginine, lysine, asparagines, and glutamine) retain primary amines in their side chains, allowing them 
to potentially interact with gold surfaces as part of a complete protein. Isothermal calorimetry has been 
used to quantify the binding strength of lysine and aspartic acid to gold nanoparticles.
74
 The side chain 
of aspartic acid does not have an amine group; however the free amino acid has an N-terminal primary 
amine. While both amino acids were found to bind the gold surface at physiological pH, the strength of 
the aspartic acid-gold interaction was much higher than the lysine-gold interaction.
74
 This difference 
was attributed to differences in amine group protonation. The authors concluded that when the amine 
group is protonated, as in the case of lysine (pI ~ 9.4), the interaction is primarily electrostatic, and 
when the amine group is deprotonated, as in the case of aspartic acid (pI ~ 2.77), the interaction is 
covalent in nature with undercoordinated atoms on the gold surface.
74
 Furthermore, amine groups on 
lysine can interact with gold surfaces and carboxyl groups in a pH-dependent manner to induce 
nanoparticle aggregation.
75
 These findings suggest that the interaction between proteins and gold 
nanoparticles is sensitive to the number of amine residues accessible at the protein surface. 
Furthermore, this interaction was found to be stronger when those groups are deprotonated, echoing the 
importance of pH as discussed in section 2.3.1.1
75
 
Protein conformation can be as important for gold nanoparticle stability as its amino acid 
composition since denaturation of proteins prior to incubation with gold nanoparticles has been shown 
to change the amount of resultant gold nanoparticle aggregation. In one study, α-amylase solutions at 
varying concentrations were incubated with 7.4 nm citrate-stabilized gold nanoparticles with or without 
prior thermal denaturation.
11
 It was shown that denaturation of amylase prior to incubation reduced the 
amount of nanoparticle aggregation observed. Green fluorescent protein (GFP), amyloglucosidase 
(AMG), and BSA solutions were also shown to cause LSPR peak-broadening to varying degrees 
depending on whether the proteins were denatured prior to incubation.
11
 It is especially notable that the 
direction of the effect observed for α-amylase and GFP was opposite that of BSA and AMG. In other 
words, denatured BSA and AMG caused more peak broadening and aggregation than their native 
counterparts. Despite the focus on surface accessible thiol and amine groups in native proteins, it should 
be noted that protein denaturation could expose groups which were previously inaccessible.
11
 Since 
there are several examples where adsorption of proteins changes their conformation
14,33,68,76
, this 
mechanism may contribute significantly to the aggregation process. These observations highlight how 
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the role of protein conformation on colloidal stability of gold nanoparticles has to be considered within 
the context of protein identity. 
If protein conformation plays a defining role in nanoparticle stability, then the amount of 
aggregation observed will likely be sensitive to extreme temperatures, since these can cause proteins to 
partially or completely lose their native conformations. The sensitivity of a particular system to 
temperature will therefore also be dependent on the thermal stability of the protein in question, with 
highly stable proteins being less sensitive to extreme temperatures, and vice versa.  
Since surfactants are commonly used to stabilize nanoparticles, their interactions with proteins must 
not be overlooked. Their denaturing effects in particular may affect protein-protein and protein-
nanoparticle interactions. Unfortunately, very little research has been conducted into the role of 
surfactants on nanoparticle interactions and resultant nanoparticle stability. Predicting the effect of 
different surfactants on protein-nanoparticle stability is a complex issue given the variety of competing 
effects including nanoparticle stabilization by adsorbed surfactants, protein denaturation by surfactants, 
and the interaction between proteins and surfactants at the gold surface. In one study, BSA was shown 
to completely displace CTAB to produce stable gold nanoparticles, which suggests that some level of 
binding competition occurs between proteins and surfactants at the gold surface.
30
 Natural bile salts 
have also been shown to partially displace β-lactoglobulin from the protein corona of 200 nm gold 
particles.
77
 If competition between protein and surfactant adsorption is a deciding factor in nanoparticle 
stability, it is likely that presence of strong bonding thiol and amine residues may bias the equilibrium 
towards protein corona formation.  
2.3.3 Additional factors 
2.3.3.1 Protein concentration 
Unsurprisingly, the concentration of proteins in solution has repeatedly been found to correlate with 
colloidal stability of gold nanoparticles. However, the relationship between concentration and stability 
remains difficult to predict. Interactions between other variables such as particle size, material, shape, 
surface chemistry, and protein identity make comparison between studies difficult. Different groups 
have reported positive
9,14,78
, and negative
11,33
 correlations between protein concentration and colloidal 
stability. For example, adsorption of cytochrome c onto gold sol particles was found to prevent 
electrolyte-induced aggregation, but only when the number of protein molecules per nanoparticle 
exceeded a certain threshold.
68
 This threshold was related to particle size as described in section 2.3.2.1. 
Several other studies have also investigated how the formation of a protein corona can stabilize gold 
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nanoparticles under conditions otherwise known to cause aggregation.
9,22,26,30
 The opposite effect has 
also been observed, whereby stable gold nanoparticles aggregate with increasing protein 
concentrations.
10,11,13,72,79
 The relationship between protein concentration and colloidal stability is not 
always linear. In several cases, distinct aggregation regimes have been observed for high, intermediate, 
and low protein concentrations. For example, an investigation by Deng et al.
71
 into the interaction of 
human fibrinogen with PAA-coated gold nanoparticles suggests that while intermediate concentrations 
of fibrinogen can aggregate nanoparticles by forming inter-particle bridges, sufficiently high 
concentrations of fibrinogen formed stabilizing coronas around each particle. Similar patterns in 
spectral absorbance were observed for citrate-stabilized gold nanoparticles
80
. This model was also 
proposed by a group studying the interaction of polystyrene (PS) and poly(methyl methacrylate) 
(PMMA) particles with IgG and fibrinogen.
81
 In these three studies, the bell-shaped response was 
attributed to the steric stabilizing nature of thick protein coronas. An alternative explanation has been 
proposed by one group, where protein-protein interactions dominate at high protein concentrations and 
the number of protein-nanoparticle interactions is effectively reduced.
72
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Figure 2.2 Protein concentration-dependent response of gold nanoparticle aggregates. a) Protein-
induced aggregation. b) Protein-induced stabilization against salt. c) Bell-shaped response to high 
and low protein concentrations. 
When determining the effect of protein concentration on nanoparticle aggregation, the method by 
which researchers adjust protein concentration is also vitally important since protein-nanoparticle 
aggregation is generally irreversible
11,27
. In cases where protein concentration is increased gradually by 
addition of protein to gold nanoparticles
11
, stabilization may never be observed since particles become 
irreversibly aggregated at moderate protein concentrations. If proteins of the corona are loosely bound 
to the surface, the inverse behavior might also be observed, whereby stabilized nanoparticles aggregate 
permanently as protein concentration is decreased, regardless of how much protein is removed. It is 
therefore important to consider that fluctuations in protein concentration may lead to irreversible 
aggregation, even if they are returned to stable conditions. 
2.3.3.2 Protein mixtures 
Studying the effect of protein concentration on gold nanoparticle stability can be further 
complicated by protein mixtures. With the introduction of other biomacromolecules, the response of 
gold nanoparticles to proteins can change given new possibilities for protein-protein and protein-
nanoparticle interactions. Multiple protein species with different affinities for gold could also lead to 
competition for binding at the nanoparticle surface.
34,82
 A large difference in binding affinity between 
proteins may mask the effect of lower affinity proteins if they cannot incorporate into the protein 
corona or if they are displaced from the surface. Similarly, proteins with similar binding affinities may 
generate mixed protein coronas
70
, producing nanoparticles with novel biological identities and colloidal 
stability. For example, while the addition of BSA or α-amylase to citrate-stabilized gold nanoparticles 
has been shown to induce particle aggregation, the effect of α-amylase concentration is dependent on 
BSA concentration when in a binary mixture.
13
 
The aggregating or stabilizing properties of proteins in mixtures can be further affected by protein-
protein interactions before or during interaction with the nanoparticle surface. For instance, one study 
which used the aggregation of negatively charged gold nanoparticles to detect positively charged 
lysozyme noted that strong electrostatic interactions between HSA (a negatively charged protein 
common in urine samples) and lysozyme could interfere with electrostatic interactions between gold 
nanoparticles and lysozyme, thereby limiting aggregation.
10
 
19 
 
Given the large number of permutations possible for protein-protein and protein-nanoparticle 
interactions in complex mixtures, extra care must be given when assessing colloidal stability of gold 
nanoparticles. Researchers must also be aware that protein effects may not be additive and that 
interference is commonplace. 
2.3.3.3 Polymeric coatings 
The nanoparticle surface can be decorated with various coatings. Often, these coatings are aimed at 
stabilizing particles against salt-induced aggregation, increasing biocompatibility, or reducing 
biofouling from non-specific protein adsorption. Some organic polymers and polyelectrolytes which 
have been used with gold nanoparticles include poly(acrylic acid) (PAA)
83
, poly(allylamine 
hydrochloride) (PAH)
51,83
 and poly(ethylene glycol) (PEG)
54,84
. PEG is the most popular organic 
polymer for stabilizing various organic and inorganic nanomaterials since it can provide high levels of 
colloidal stability as well as improved biocompatibility, an important feature for in vivo applications. 
Many studies have shown that coating gold
85,86
 and silver nanoparticles
55
 with PEG increases their 
stability in aqueous media of various ionic strengths. Manson et al.
86
 observed a positive relationship 
between the capping density of PEG on gold nanoparticles and their stability. An increased density of 
PEG on the surface is also likely to increase particle stability in protein solutions by discouraging 
protein adsorption
70
. Additionally, coating with polyelectrolytes such as PAA and PAH can confer a 
strong positive or negative zeta potential which contributes to electrostatic particle behavior
51
 as 
discussed in section 2.3.1. 
The anti-biofouling properties of certain polymers are popular among those pursuing in vivo 
applications since the formation of a protein corona can be detrimental to the function and stability of 
nanoparticles. Several groups have shown that PEG can reduce adsorption of BSA
38,87,88
 and other 
proteins
70,89
 to gold surfaces. When fibrinogen
90
 and lysozyme
89
 were found to induce aggregation of 
gold nanoparticles, coating nanoparticles with PEG prior to protein exposure reduced adsorption and 
prevented aggregation. Contrary to these results, some studies observed significant adsorption of BSA, 
regardless of PEG functionalization.
51
 A thermokinetic study of BSA adsorption onto PEG, PAA, and 
PAH coated gold nanoparticles concluded that BSA adsorption occurs with all three coatings.
51
 
However, it was noted that the adsorption rate was slower for PEG- and PAA-AuNPs compared to 
PAH-AuNPs, presumably due to the net negative charge of BSA at pH 7
51
. Even in cases where 
PEGylation of AuNPs was shown to reduce protein adsorption, not all proteins were similarly affected. 
Strong adsorption of positively charged lysozyme to slightly negative PEG-AuNPs resulted in charge 
neutralization and in some cases induced aggregation.
87
 While it is commonly believed that reducing 
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the amount of protein adsorption will benefit stability, the presence of free proteins in solution can also 
cause depletion-aggregation of nanoparticles decorated with ethylene glycols
38
, without the need for 
direct surface adsorption. Given the mixed results of PEG, it is clear that these nanoparticle coatings do 
not provide a universal solution to particle stability against non-specific adsorption, especially in 
complex media containing multiple protein identities. 
It should be noted that the presence of excess PEG in solution (not attached to the nanoparticle 
surface) can itself affect colloidal stability of gold nanoparticles via depletion stabilization
43
. Here, low 
molecular weight (Mw) PEG was found to promote depletion attraction (aggregation) while high Mw 
PEG promoted depletion repulsion (stabilization). This mechanism of stability is advantageous over 
polymer coating and protein corona stabilization since it leaves the surface free for attachment of other 
molecules
43
. However, free PEG may not have the same anti-biofouling properties as surface-attached 
PEG, and may not be as effective in preventing nanoparticle aggregation due to bridge flocculation. 
2.4 Applications 
A number of gold nanoparticle applications have arisen which may be sensitive to protein 
interactions. In some cases, unwanted protein fouling of nanoparticle surface could cause aggregation 
and prevent cellular uptake of therapeutic nanoparticles.
91
 In other cases, the deposition of proteins on 
the surface could be used to enhance biocompatibility, increase colloidal stability, and increase 
circulation times.
92
 Again others will be primarily concerned with how particles become aggregated or 
stabilized in solutions for protein sensing or diagnostic applications.
9–11,79
 Here, we present some 
applications for which protein-nanoparticle interactions and colloidal stability are a concern, and 
address possible limitations. 
2.4.1 Sensing and diagnostics 
2.4.1.1 Conventional protein methods 
Proteins play a vital role in countless biochemical and physiological processes. Variations in 
protein concentration or function can often be associated with ongoing biological process and overall 
health. Given their importance, the ability to detect and quantify proteins is a fundamental part of many 
bioanalytical and clinical investigations.
1,93,94
 Conventional methods for protein quantification include 
the Bradford, bicinchoninic acid (BCA), and Lowry assays. These assays function based on the 
interaction between peptide bonds or aromatic residues in proteins with one or more chemical reagents 
to produce a colour change at a particular wavelength. The amount of colour change can then be used to 
estimate total protein concentration based on a standard curve. While these colorimetric assays are 
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relatively simple to perform, they cannot be used for protein identification since the response obtained 
is not specific to a given protein. The identification of proteins in solution is much more challenging 
than quantification. Gel-based assays such as polyacrylamide gel electrophoresis (PAGE) may provide 
an approximate size for a protein, but this alone cannot be used for conclusive identification since many 
polypeptides share similar molecular weights. Western blotting, enzyme-linked immunosorbent assays 
(ELISA), and protein microarrays can be used for protein identification, but only when paired with 
antibodies for the target of interest.
95
 Furthermore, the lock-and-key model protein protein-antibody 
interaction necessitates that a probe be pre-selected for every analyte of interest. This, plus the difficulty 
and cost of obtaining target-specific probes can increase the complexity and cost of probe-based 
identification assays. Protein mass spectrometry is a powerful tool for identification but requires 
specialized training and expensive equipment. These factors make conventional methods impractical 
for the majority of point-of-care and consumer-level applications. The ideal protein assay would permit 
concurrent protein identification and quantification, while reducing overall cost and complexity. 
2.4.1.2 Gold nanoparticle methods 
The use of non-functionalized gold nanoparticles for colorimetric protein quantification was being 
explored as early as 1986, when it was demonstrated that the absorbance spectrum of colloidal gold 
undergoes red-shifting and peak broadening in response to BSA concentrations as low as 20 ng/mL (0.7 
nM)
79
. Here, BSA solutions were incubated with commercially available colloidal gold nanoparticles 
and aggregation was monitored using characteristic changes in their absorption spectra. The main 
interfering factors identified by the author were variations between purified proteins, changes in 
solution pH, and the presence of surfactant (i.e. sodium dodecyl sulfate (SDS)). To avoid errors in 
quantification due to variation between proteins, the author recommended comparing samples to a 
protein standard containing the same species at known concentrations. The author also noted that this 
variation becomes less important with protein mixtures, where an averaging effect may occur, except in 
cases where one protein is dominant in a sample. The importance of solution pH supports the notion of 
electrostatic interaction between proteins and nanoparticles since changes in pH would affect the 
protein net charge, as discussed in section 2.3.1.1. Additionally, the presence of SDS likely impacts 
protein conformation and charge, thereby altering the response of colloidal gold. While not explicitly 
presented as sensing platforms, other studies have shown similar concentration-dependent responses 
which could be adapted to quantify protein concentration if paired with suitable protein standards.
33,38,96
 
Aside from protein concentration, gold nanoparticles have also been used to quantify the degree of 
protein denaturation.
11
 Here, citrate-stabilized gold nanoparticles were exposed to four globular proteins 
22 
 
(α-amylase, GFP, AMG, and BSA). Thermal denaturation of proteins prior to incubation with 
nanoparticles changed the observed peak response. Since transmission electron microscopy (TEM) 
confirmed that changes in absorption spectrum were a result of nanoparticle aggregation and not solely 
protein adsorption, the authors concluded that protein conformation could be determined by monitoring 
the degree of gold nanoparticle aggregation. The lower limits of detection ranged between 2 and 330 
ng/mL (40 pM – 12 nM), while the upper limits ranged between 0.1 and 3.85 μg/mL (2-143 nM), 
depending on the protein identity and conformation. The effect of protein conformation on nanoparticle 
response was not uniform between the four proteins and the authors related these variations to the 
distribution of thiol groups, as discussed in section 2.3.2.2. Further studies by the same group used this 
method to determine the proportion of native and denatured proteins in a mixture.
97
 While the 
distinguishing feature of this assay over conventional methods is the ability to discriminate between 
native and denatured proteins, care must be taken to ensure that protein denaturation does not lead to 
under- or over-estimation of protein concentration. 
The quantification of individual proteins within the complex medium of a biological sample poses 
several difficulties. Most prominent of these are low concentrations of the target protein and the 
presence of many other interfering proteins. An investigation into detection of urinary lysozyme using 
anionic citrate-capped gold nanoparticles proposed a quantitative assay which leverages the high pI of 
lysozyme, relative to other proteins.
10
 The authors suggest that positively charged lysozyme will bind 
preferentially to anionic gold nanoparticles, conferring some specificity to the assay. They also noted 
the relationship between solution pH and protein pI on nanoparticle aggregation, as discussed in section 
2.3.1.1. Using gold nanoparticles to quantify lysozyme in aqueous solutions, the authors reported 
detection ranges between 10 and 60 nM which were also related to particle size (larger particles had 
higher detection limits). As with all the assays proposed thus far, variations in the adsorptive properties 
of lysozyme and other proteins on citrate-stabilized gold nanoparticles must be controlled to ensure 
repeatable aggregation behavior. 
Nanoparticle aggregates can also be used for surface-enhanced Raman spectroscopy (SERS). The 
locations at which two separate nanoparticles touch are functionally similar to spiky gold nanoparticles 
which enhance electromagnetic fields, leading to a stronger Raman signal.
98,99
 One application of gold 
nanoparticle aggregates for SERS was demonstrated by Jung et al.
98
. Here, pH sensitive “SMART” 
gold nanoparticles aggregate following uptake by cancer cells and showed distinct Raman peaks from 
the nanoparticle surface. While aggregation is beneficial for this strategy of Raman surface 
enhancement, sub-nanometer gaps are critical for maximum SERS enhancement
99
 and it is possible that 
thick protein coronas could keep particles far enough apart to reduce this effect. 
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Given that viral capsid is composed of proteins, it is possible that developments in protein-
nanoparticle interactions can be expanded to applications in viral sensing and analysis. The binding 
ratio between gold nanoparticles and viruses will depend on their relative size, but the comparable size 
of nanoparticles and viruses presents an interesting question of whether nanoparticles will aggregate 
given the limited number of surface interactions possible. One potential aggregation mechanism, 
similar to that previously identified 
81
 would be inter-particle bridge formation between individual 
particles and whole viruses. Alternatively, individual proteins may interact with gold nanoparticle if the 
viral capsid is disassembled. 
2.4.2 Therapeutics  
Photothermal therapy (PTT) is being heavily investigated as a method for cancer treatment. In brief, 
nanomaterials capable of converting near-infrared (IR) radiation into heat accumulate in tumors and are 
irradiated to generate localized hyperthermia which kills or damages cells. Gold nanoparticles are 
among the most promising PTT materials.
100
 Their size and aspect ratio can be controlled to tune 
absorbance to the “tissue optical window” of 650-1350 nm where light can penetrate deep into tissue 
while maintaining dimensions that permit uptake by cells.
101
 Aggregation of gold nanoparticles prior to 
accumulation in tumors could reduce this effect and shorten circulation times since nanoparticle size 
strongly influences clearing rates.
102
 Instead of tuning individual particle size and shape for increased 
uptake and near-IR heating, small gold nanoparticles can also be used which form large aggregates 
upon cellular uptake, shifting their absorbance to the near-IR region by plasmon coupling.
103
 For 
instance, nanoparticles have been coated with pH-responsive molecules which aggregate by adopting 
positive and negative charges under the mildly acidic intracellular conditions.
98,104
 As in the first 
strategy, extracellular aggregation may hinder uptake by cancer cells and must be avoided. However, 
this method relies on particles to aggregate once inside tumor cells. In the event that adsorption of 
proteins produces a stabilizing corona and prevents electrostatic aggregation, plasmon coupling will not 
occur and photothermal efficiency will diminish. 
Finally, gold nanoparticle-protein aggregates have also been proposed for drug-delivery. In one 
study, lysozyme was used to induce aggregation of citrate-stabilized gold nanoparticles and form large 
protein-nanoparticle complexes.
105
 These complexes were then loaded with a hydrophobic or 
hydrophilic drug. BSA was used to stabilize the protein-nanoparticle complexes by forming an external 
stabilizing layer. This application is particularly interesting with regards to protein adsorption and 
colloidal stability since it uses proteins for both destabilization (formation of drug-carrying 
agglomerates) and stabilization (to prevent further aggregation of these complexes in vivo). Lysozyme 
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is a clear choice for forming gold nanoparticle aggregates since it has a pI near 11, rendering it 
positively charged at physiological pH, and several groups have observed lysozyme-induced 
aggregation of negatively charged gold
10,89
 and silica nanoparticles
81
. The adsorption of BSA was also 
noted by the authors as benefiting not only the stability of drug carrying agglomerates, but also 
improving carrier uptake by cancer cells.
105
 
2.5 Conclusion 
The colloidal stability of gold nanoparticles is a fundamental consideration for nanotechnology 
applications. Many virtues of nanoparticles are directly related to their aggregation state. Despite 
extensive research in the field, there is much room for improvement in our ability to predict and control 
nanoparticle aggregation. For many biological samples, non-specific nanoparticle-protein interactions 
remain the crux of this issue as these interactions have proven to be highly multifaceted. In most cases, 
the aggregation or stability of gold nanoparticles is determined by numerous interacting factors such as 
medium ionic strength, pH, protein charge, nanoparticle charge, protein structure, and surfactant 
concentration. It is therefore important to consider the complex interactions between these factors when 
designing gold nanoparticle applications for in vivo and in vitro applications. 
In this review we have outlined several key factors which have been shown to affect gold 
nanoparticle-protein interactions and their resultant effect on colloidal stability. We have also shown 
how these factors may become interrelated in their effects. By this method, we have highlighted the 
complexity with which proteins and gold nanoparticles interact. Unfortunately, this complexity is not 
fully appreciated by many articles in the field. This hinders the development of gold nanoparticles for 
point-of-care or field use. By acknowledging these factors, we can begin to reconcile contradictions 
over nanoparticle behavior, thereby furthering the potential of gold nanoparticles in biological 
applications.  
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Chapter 3 
“Chemical nose” biosensor for detecting proteins in complex 
mixtures 
3.1 Summary 
A growing understanding of the fundamental role of proteins in diseases has advanced the 
development of quantitative protein assays in the medical field. Conventional techniques for protein 
analysis include ELISA, western blotting, mass spectrometry and various quantitative assays (e.g. 
Bradford, Lowry, BCA). However, many of these conventional strategies require specialized training, 
expensive antibodies, or sophisticated equipment, raising assay costs and limiting their application to 
laboratory analysis. Here, we present the application of a “chemical nose” type colorimetric gold 
nanoparticle sensor for detection, quantification, and identification of single proteins, protein mixtures, 
and proteins within the complex environment of human serum. The unique interactions between a 
mixture of two different gold nanoparticle morphologies (spherical and branched) and six separate 
proteins (bovine serum albumin, human serum albumin, immunoglobulin G, fibrinogen, lysozyme, and 
hemoglobin) generated distinguishable protein- and concentration-dependent absorption spectra, even 
at nanomolar concentrations. Furthermore, we show that this response is sensitive to the relative 
abundance of different proteins in solution, permitting analysis of protein mixtures. Finally, we 
demonstrate the ability to distinguish human serum samples with and without a clinically relevant two-
fold increase in immunoglobulin G, without the use of expensive reagents or complicated sample 
processing. 
3.2 Introduction 
Protein detection, identification, and quantification assays have diverse applications ranging from 
biomedical diagnostics and health monitoring
107,94,93
, to environmental
108,109
 and consumer 
protection
110,111
. While several methods for protein identification are commercially available, many 
conventional methods such as ELISA are not well-suited for consumer level or point-of-care 
applications due to procedural complexity, equipment requirements, or high assay cost. Furthermore, 
these assays generally rely on “lock and key” models for protein detection, whereby a specific antibody 
is required to detect a protein of interest and detection of multiple proteins requires several antibodies. 
The detection of multiple analytes simultaneously, commonly referred to as multiplexing, allows for 
more complete analysis of biological samples. However, multiplexed protein analysis often employs 
several probes (e.g. protein microarray)
112
 or specialized equipment such as mass spectrometers
94
. 
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Increasing accessibility of multiplexed protein analysis will require the development of new 
biosensing techniques that lower cost and equipment requirements. Colorimetric nanosensor platforms 
are increasingly studied for biosensing applications in research, clinical, and consumer level 
environments due to their ease-of-use, and high sensitivity.
3,52,113
 Among these platforms, gold 
nanoparticles are popular due to their unique optical properties.
114,115
 As particle size increases, or 
particles aggregate in solution, their electromagnetic absorption peak shifts to longer wavelengths.
4,57,116
 
Since the peak wavelengths for gold nanoparticles typically fall within the visible range of the 
electromagnetic spectrum, these shifts can be perceived as changes in color without specialized 
equipment.  
One common method for protein detection using gold nanoparticles is to functionalize them with 
target-specific probes such as antibodies, peptides, or aptamers. These surface-bound molecules can 
then bind to freely diffusing proteins, thereby forming inter-particle bridges and producing a 
colorimetric response. However, this “lock and key” strategy for detecting proteins suffers from similar 
limitations to conventional methods. As a result, probe-functionalized gold nanoparticles are not 
optimal for low-cost broad-spectrum protein analysis. Another strategy relies on the displacement of a 
fluorophore from the gold nanoparticle by a target analyte.
117
 In this case, analyte presence is monitored 
by changes in fluorescence rather than absorbance. An array of nanoparticles with different surface 
modifications and protein interactions can be used to establish an identifying fingerprint, but the need 
for fluorophores and fluorescence measurements raises manufacturing and equipment requirements. 
While certain strategies use probes for protein-specific binding, it is also well known that protein 
adsorption can occur non-specifically on the surface of both metallic and non-metallic 
nanoparticles
81,90,118
. The collection of proteins adsorbed onto the surface of these nanoparticles is 
known as the protein corona and has been shown to affect stability of nanoparticle solutions. For 
instance, some studies suggest that adhesion of proteins onto gold nanoparticles can increase their 
stability and may prevent in vivo aggregation.
76,88
 Other studies show that the presence of certain 
proteins can destabilize nanoparticle solutions.
11,81,89
 Furthermore, the degree of protein coverage and 
particle stability is often related to protein concentration.
31,81
 While the effect of protein adsorption and 
corona formation on nanoparticle stability is commonly studied due to its impact on diagnostic and 
therapeutic platforms, few studies have investigated how these non-specific interactions can be used for 
protein identification and sensing.
9–11,79
 
In a “chemical nose” system, several different responses to a single analyte are used to construct a 
unique fingerprint for that analyte, thereby improving distinction over a single-response system. This 
27 
 
has been previously demonstrated for detection of bacteria using gold nanoparticles.
119
 Since 
nanoparticle morphology plays a key role in protein-nanoparticle aggregation, the response of different 
shapes can also be used in a “chemical nose” for improved distinction between proteins. In this study, 
we show that branched and spherical CTAB-coated gold nanoparticles produce unique colorimetric 
responses to different proteins, and that a 1:1 (v:v) mixture of the two (from now on, referred to as 
“chemical nose” solution) can be used to discriminate between six proteins: bovine serum albumin 
(BSA), human serum albumin (HSA), immunoglobulin G (IgG), lysozyme (Lyz), fibrinogen (Fib), and 
hemoglobin (Hgb). We also demonstrate how relative abundance of proteins in a binary mixture can be 
determined based on this response. Finally, we use this platform to detect elevated globulin levels in 
human serum, which can serve as an indication of disease status and predictor of mortality in cancer 
patients
2,120–124
. 
3.3 Materials and Methods 
3.3.1 Materials 
Gold (III) chloride hydrate (HAuCl4·xH2O), cetyltrimethylammonium bromide (CTAB), sodium 
borohydride, silver nitrate, hydrochloric acid, nitric acid, sodium hydroxide, L-ascorbic acid, bovine 
serum albumin (A2153), albumin from human serum (A1653), IgG from human serum (I4506), 
fibrinogen from human plasma (F3879), lysozyme from chicken egg white (L6876), human 
hemoglobin (H7379), and human serum (H4522) were purchased from Sigma-Aldrich (Oakville, ON, 
Canada). Trisodium citrate dihydrate and BupH phosphate buffered saline packs were purchased from 
Thermo Fisher Scientific (Burlington, ON, Canada). Sterile UV-star 96-well microplates, scintillation 
vials (20 mL), sodium chloride (ACS grade), Nalgene sterilization filter units (0.2 µm pore size), 15 mL 
polypropylene centrifuge tubes, and 1.7 mL polypropylene microcentrifuge tubes were purchase from 
VWR (Mississauga, ON, Canada). 400 mesh formvar/carbon coated copper grids were purchased from 
Canemco Inc (Gore, QC, Canada). All procured chemicals were used without further purification. The 
20 mL vials used for gold nanoseed synthesis were cleaned using 12M sodium hydroxide and larger 
glassware was cleaned using aqua regia as described in a previously published protocol
125
. Water used 
for the preparation of solutions was purified using a Millipore water filtration system to an electrical 
resistivity greater than 15 MΩ∙cm. 
3.3.2 Synthesis of gold nanoparticles 
CTAB-coated gold nanoparticles were synthesized according to a previously published protocol
65
. 
All synthesis solutions were prepared in Millipore water (>15 MΩ∙cm). Briefly, gold seed precursor 
was prepared by adding 60 μL of ice-cold sodium borohydride to a solution containing 18.812 mL of 
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Millipore water, 188 μL of 10 mg/mL gold (III) chloride, and 1 mL of 2 mM trisodium citrate under 
vigorous stirring. Following addition of sodium borohydride, the solution was stirred for 1 minute and 
left to mature overnight under dark ambient conditions. Nanoparticle growth solution (221.76 mL) was 
prepared under moderate stirring by adding 8.974 mL of 11 mM gold chloride, 1.344 mL of 5 mM 
silver nitrate, and 1.442 mL of 100 mM L-ascorbic acid to 210 mL of either 1.47 mM or 7.33 mM 
CTAB (for spherical (red) and branched (blue) nanoparticles respectively). Finally, 5.6 mL or 2.24 mL 
of gold seed precursor (for spherical (red) and branched (blue) nanoparticles respectively) was added to 
the nanoparticle growth solution, and stirred for an additional 1.5 minutes, at which point the solution 
was incubated overnight under dark ambient conditions. The final nanoparticle solution was pelleted 
via centrifugation (16000 RCF for 15 minutes) and resuspended in 1 mM CTAB solution. 
3.3.3 Protein solutions 
Prior to reconstitution of lyophilized proteins, BSA, HSA, IgG, fibrinogen, lysozyme, and 
hemoglobin were stored at -5 
o
C or -20
oC, as per supplier’s recommendation. Fresh protein solutions 
were prepared prior to each experiment. Solutions were prepared by weighing out the appropriate 
amounts of protein into a microcentrifuge tube, and reconstituting in a calculated volume of purified 
water, sterile saline, or sterile phosphate-buffered saline (PBS), to the desired final concentration. 
Lower ionic strength saline and PBS (1/4X and 1/16X) were prepared by diluting stock (1X) NaCl and 
PBS solutions (I = 450 mM) in Millipore H2O at 1:3 or 1:15 ratios. After reconstitution, protein 
concentrations were adjusted by measuring absorbance at 280 nm (A280) using an Epoch
TM
 Microplate 
Spectrophotometer. Molar concentrations were determined using the Beer-Lambert Law: 
                 (Eq. 3.1) 
where   is the optical density (OD) of the sample,   is the molar absorption coefficient of the protein 
obtained from the supplier or literature (Table 3.1),   is the optical path length, and   is the molar 
concentration of the protein solution.  
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Table 3.1 Physical and optical parameters of proteins used for concentration determination. 
Adapted from Moyano et al.
117
 
Protein Mw E280 
(10
3
/M
-1
cm
-1
) 
A280 
(4.5 μM) 
Reference 
BSA 66.4
 
44.3 0.199 Sigma-Aldrich 
HSA 66.5
 
35.3 0.159 Sigma-Aldrich 
IgG 150
 
210 0.945 Moyano 2011 
Fib 340 513 2.310 Sigma-Aldrich 
Lyz 14.3
 
37.8 0.170 Moyano 2011 
Hgb 64.5 130 0.585 Sigma-Aldrich 
 
Serial dilutions were performed to obtain solutions varying in concentration from 450 μM to 27.5 
nM. After adding 200 μL of gold nanoparticle solution to 100 μL of each protein sample, the final 
protein concentrations were one third the normalized concentration, such that final solutions ranged 
from 150 μM to 9.2 nM. Final concentrations following dilution in the 96-well plate were confirmed by 
adding 200 μL of Millipore H2O to 100 μL of the respective protein dilution, and measuring absorbance 
at 280 nm. Due to limitations in A280 quantification, protein concentrations were calculated directly 
from absorbances where absorbance was in the linear range of the spectrophotometer (0.1-2.0), and 
extrapolated for samples beyond this range. Protein concentrations presented in the results and 
discussion section represent molar concentrations following the 1/3 dilution, as determined using A280. 
For protein identification assays, protein solutions were adjusted to a final concentration of 4.5 μM 
using A280 (Table 3.1), and diluted 1/10 in 1/4X PBS for a final concentration of 450 nM. After adding 
200 μL of gold nanoparticle solution to 100 μL of each protein identification sample, the final protein 
concentration was 150 nM. For mixtures of HSA and IgG, individual protein concentrations were first 
adjusted to 450 nM as previously describes, then mixed by volume to obtain the desired mole fractions 
of HSA and IgG such that the total protein concentration following addition of nanoparticles was 150 
nM. 
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3.3.4 Serum preparation with IgG 
Human serum samples for baseline IgG levels were diluted 20X in 1/4X PBS without any added 
protein. Serum samples for elevated IgG levels were diluted 20X in 1/4X PBS containing 3.42 μM IgG. 
The resultant IgG concentrations prior to incubation with gold nanoparticles were approximately 3.25 
μM for baseline serum (based on average IgG concentrations for human adult males) and 6.5 μM for 
high IgG serum, a two-fold increase assuming a mean total IgG concentration of 65 μM in healthy adult 
males
126
. 
3.3.5 Protein-gold incubation 
Concentration-dependent response, protein identification, and serum experiments were assessed 
spectrophotometrically in a transparent 96-well plate. 100 μL of each protein sample or solvent control 
was added to the 96-well plate. Triplicate samples for each dilution were used for concentration-
dependent response, and eight replicates were used for identification and serum tests. 200 μL of the 
gold nanoparticle solution was then added to each well containing protein or control solution. Plates 
were then placed on a Stovall Belly Dancer orbital shaker (Peosta, IA, USA) for 2 minutes prior to 20 
hour incubation in the dark at room temperature. Following incubation, an Epoch
TM
 Microplate 
Spectrophotometer (Winooski, VT, USA) was used to obtain spectral scans for each well containing 
gold nanoparticles. Spectra were collected from 300-999 nm wavelengths, in increments of 1 nm. 
3.3.6 Quantifying gold nanoparticle response 
The extent of gold nanoparticle aggregation was quantified by monitoring changes in peak 
absorbance relative to the solvent control. First, the position of the absorbance peak for the 1/4X PBS 
control (1
o
 peak in wavelength nanometers) was determined from control spectral scans. Absorbance 
values at the 1
o
 peak position were then noted for samples containing protein. Baseline absorbance at 
800 nm was then determined for each sample. Peak height was calculated by subtracting each sample’s 
baseline absorbance (800 nm) from the sample’s absorbance at the 1o peak position: 
                         
                                   (Eq. 3.2) 
Peak heights were then normalized against the control to obtain a normalized response for each protein 
sample: 
                                                         (Eq. 3.3) 
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Statistical significance between peak heights for baseline and elevated IgG serum samples was 
determined using Microsoft Excel
®
 via an independent two-tailed heteroscedastic t-test. A 
heteroscedastic t-test was used due to unequal variances in the baseline and elevated samples. 
3.3.7 Protein classification 
Principal Component Analysis (PCA) was conducted using MATLAB
®
. Protein solutions were 
grouped based on the resultant gold nanoparticle absorbance spectrum. Due to the broad extent of 
spectral shifts observed during protein-induced aggregation, all 700 wavelengths of the spectrum (300-
999 nm) were used for classification. Confidence ellipses (95%) were also calculated using MATLAB
®
. 
3.3.8 Transmission electron microscopy 
Gold nanoparticle sizes and shapes were confirmed using a Phillips (Eindhoven, The Netherlands) 
CM10 TEM. Copper TEM grids (400 mesh formvar/carbon coated) were prepared under ambient 
conditions by overnight evaporation of a 5 μL droplet of gold nanoparticle solution directly onto a grid. 
TEM micrographs were analyzed using ImageJ. 
3.4 Results and Discussion 
3.4.1 Ionic strength 
The majority of protein detection and identification experiments are performed in aqueous 
solutions. Since it has been shown that ions can mediate both the colloidal stability of gold 
nanoparticles in solution
35,127
, as well as the electrostatic interaction between proteins and gold 
nanoparticles
51
, it was important to choose a salt concentration which would maximize the performance 
of our assay. In the absence of proteins, high salt concentrations can be used to destabilize gold 
nanoparticles.
43,44
 With proteins in solution, the ionic composition of a medium can affect both protein-
protein interactions
128
 and protein adsorption on surfaces
29
. To determine the optimal ionic 
concentration for protein-induced “chemical nose” aggregation, serial dilutions of BSA were prepared 
in deionized water, saline (NaCl), or PBS at varying salt concentrations, such that the final ionic 
strengths of NaCl and PBS were 450, 112.5, or 28.125 μM (from now on referred to as 1X, 1/4X, and 
1/16X, respectively). These concentrations were chosen since they are below the experimentally 
observed salt concentration which causes gold nanoparticle aggregation. The results are shown in 
Figure 3.1. 
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Figure 3.1 Concentration-dependent aggregation of “chemical nose” nanoparticles to BSA 
solutions of different ionic strength and composition. 
In all observed cases, protein solutions dissolved in PBS induced nanoparticle aggregation at lower 
protein concentrations than those dissolved in NaCl with the same ionic strength (Figure 3.1). This 
suggests that polyionic species (e.g. phosphate groups in PBS) have a larger effect on mediating 
nanoparticle aggregation. The increase in aggregation at lower protein concentrations is favourable for 
high sensitivity detection assays. Additionally, solutions of 1/4X NaCl and 1/4X PBS outperformed 
their higher and lower ionic strength counterparts, while pure deionized Millipore H2O was the least 
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sensitive. These findings suggest the existence of an optimal ionic environment which facilitates 
protein-induced nanoparticle aggregation. For optimal performance at low concentrations, subsequent 
experiments were performed by diluting protein and/or serum in 1/4X PBS. 
3.4.2 Shape-dependent response 
In order to have good distinction between proteins, it is necessary to obtain several unique 
responses to the same analyte. The proteins can then be identified based on the unique pattern or 
fingerprint of responses. One simple method for changing the response of gold nanoparticles is to 
change their morphology. By changing gold nanoparticle shape (i.e. from spherical to branched) we can 
alter their optical absorbance spectra and how they interact with their environment. This technique has 
been previously demonstrated only for the detection of bacteria.
65,119,129
  
It should be noted that variations in nanoparticle synthesis procedures can affect nanoparticle 
morphology, resulting in slight variations of size, surface features, edge angles, or overall shape. Given 
the potential effect of morphology on gold nanoparticle-protein interactions, variability in gold 
nanoparticle shapes could lead to different responses. However, repeated studies using the above-
mentioned synthesis procedure have optimized shape-control of branched and spherical nanoparticles 
with respect to both particle size and degree of branching 
65,129
. Previous statistical analysis of particles 
produced by this method has shown that the configuration of seed and surfactant used in this study 
yields a small distribution of spherical particles with diamaters of approximately 32 nm, and consistent 
branched particles with approximate diameters of 60 nm and an average of 5.5 branches which are on 
average 9 nm long 
65
. The spectrophotometric profiles of nanoparticles used in the current study also 
match those collected previously. This optimization allows for repeated synthesis of nanoparticles with 
minimal variation in morphology or optical properties between batches. Furthermore, the crystalline 
structure of gold nanoparticles is an important consideration for protein-nanoparticle interactions since 
it can define overall particle morphology following nanoparticle growth. In the previously described 
method, silver ions are deposited onto gold nanoseed by underpotential deposition (UPD)
65
. These ions 
then create active sites for nanoparticle branch formation. Since underpotential deposition favours 
certain crystal facets
130
, the crystalline structure will influence active site formation and, by extension, 
branch orientation which could ultimately affect the protein-nanoparticle interaction. 
Here, we have optimized the detection conditions to get a differential response in the presence of 
different proteins. To determine whether these two nanoparticle morphologies respond differently to 
proteins, we incubated branched (Figure 3.2A), spherical (Figure 3.2B), and a 1:1 mixture of both with 
BSA, IgG, and a protein-free medium (1/4X PBS). At a concentration of 150 nM, both BSA and IgG 
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induced nanoparticle aggregation, as evidenced by decreases in absorbance intensity, red-shifting of the 
spectrum, and broadening of the absorption peak (Figure 3.3).  
 
Figure 3.2 TEM micrographs of A) branched (blue) and B) spherical (red) nanoparticles. Scale 
bars represent 20 nm. 
A difference in response between spherical and branched morphologies was also apparent. While 
the absorbance peak for branched nanoparticles was completely flattened in the presence of both BSA 
and IgG, BSA only induced partial flattening in spherical nanoparticles (Figure 3.3B) whereas IgG 
induced complete flattening (Figure 3.3C). For both proteins and the negative control, the absorbance of 
the “chemical nose” solution has features resembling both spherical (red) and branched (blue) curves, 
suggesting that both nanoparticle morphologies contribute to the final spectrum when mixed together. 
When two or more nanoparticles are combined together with drastically different peak absorbance 
wavelengths, then it may be possible to observe both maxima in the combined solution. In this way, 
aggregation of both particles might be monitored independently based on absorbance at their 
corresponding wavelengths. The combination of two or more nanoparticle morphologies in this way 
can provide added discriminatory power from a single sample well, thereby simplifying the assay.
129
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Figure 3.3 Absorbance spectra for spherical, branched, and mixed (spherical and branched, 1:1 
by volume) nanoparticle solutions when incubated with A) PBS, B) 150 nM BSA, or C) 150 nM 
IgG. Average curves are shown (n = 8). 
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3.4.3 Concentration-dependent response 
Several investigations have observed concentration-dependent effects of proteins on gold 
nanoparticle aggregation and adsorption.
11,79
 Despite extensive interest in the field, many confounding 
factors make characterizing the aggregation mechanisms difficult. Observed effects can be influenced 
by protein identity
69
, protein concentration
11
, nanoparticle coatings (e.g. PEGylated surfaces
89
, citrate-
stabilization or CTAB-stabilization
40,76
), medium (e.g. DI H2O, PBS
40
, NaCl
88
, citrate
76
), and 
experimental set-up
11,81
. To determine the concentration-dependent aggregation of CTAB-coated gold 
nanoparticles to the proteins in this study, fifteen 2X serial dilutions were prepared for each protein in 
1/4X PBS. The resulting protein concentrations ranged from 450 μM to 27.46 nM (BSA, HSA, Lyz, 
Hgb) and from 28.125 μM to 1.72 nM (IgG, Fib). Lower concentrations of IgG and Fib were used due 
to preliminary results, which showed higher response for these proteins. By combining these solutions 
(100 μL) with gold nanoparticles (200 μL) in a 96-well plate, the final protein concentrations were 
further diluted to one third of these values. A negative control containing only 1/4X PBS serves as a 
baseline for comparison. Within 1 minute of nanoparticle addition, several protein dilutions displayed a 
visible change in color when compared to the negative control. This color change progressed rapidly for 
the first 10 minutes of incubation. To allow sufficient time for assay color to stabilize, samples were 
incubated for 20 hours under dark ambient conditions. Figure 3.4 shows the resulting aggregation 
response curves, presented as a peak-height difference between sample and control. 
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Figure 3.4 Concentration-dependent aggregation of CTAB-stabilized “chemical nose” to different 
proteins. Higher normalized response, defined as the difference in absorbance peak height 
between sample and control, indicates more aggregation. Mean response values (n=3) are 
presented ± S.D. 
Each protein exhibits a unique concentration-depending aggregation curve. Furthermore, while 
BSA and HSA share similar structures, isoelectric points, and 76% amino acid sequence identity, their 
response curves are clearly distinguishable. While some proteins (BSA, HSA, IgG) lead to significant 
change in absorbance over a wide range of concentrations (73 μM to 5 nM), others respond only at 
certain concentrations (Fib, Hgb), while the remainder produce little to no response (Lyz). The bell-
shaped response common to BSA, HSA, and IgG suggests the existence of different aggregation 
regimes for high, moderate, and low protein concentrations. Previous studies have described similar 
bell-shaped response curves when exposing negatively-charged polystyrene and PMMA nanoparticles 
to IgG.
81
 The authors of this study proposed that high protein concentrations saturate the particle 
surface, reducing the overall aggregate size, while intermediate concentrations allow for aggregation by 
bridge formation where a single protein can bind to more than one nanoparticle. Other studies showed 
that progressive addition of BSA to a citrate-stabilized AuNP solution leads to an increase in 
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aggregation up to a saturation point beyond which no more aggregation occurred.
11
 It is likely that the 
bell-shaped response was not observed by this group since protein concentration was steadily increased 
and irreversible particle aggregation occurred before the surface was saturated with protein. In this 
parallel comparison of several different proteins under identical conditions, we were able to discern 
varying ranges of aggregation and sensitivity. 
3.4.4 Protein Identification 
The ability to distinguish between different proteins is another valuable aspect of broad-spectrum 
biomolecular sensing. A multiplexed system of functionalized gold nanoparticles where different 
nanoparticles bind to different targets has been proposed
131
, but the requirement to have one 
nanoparticle per protein limits the variety of proteins which can be identified. To assess the potential for 
protein discrimination at nanomolar concentrations using non-specific gold nanoparticle solutions, we 
prepared six protein solutions and normalized their concentration to 450 nM using absorbance at 280 
nm. Each protein was then incubated with the “chemical nose” solution such that the final protein 
concentration was 150 nM. Within 1 minute of gold nanoparticle addition, BSA, HSA, and IgG were 
noticeably different in appearance than the 1/4X PBS control. The differences between Fib, Lyz, Hgb, 
and control were less noticeable. Even after 20 hours of incubation, these samples were not appreciably 
different to the unaided eye. Following incubation, full spectral scans revealed protein-dependent 
variations in absorption spectra. Average absorption curves for each protein are plotted in Figure 3.5A 
and show the difference between equimolar solutions. The contour plot in Figure 3.5B highlights 
sample-to-sample similarity of the 6 proteins, where the horizontal layers within each plot represent 8 
replicates. PCA classification of these spectra established that the first two principal components could 
account for 98.7% of the observe variability. A biplot of PCA scores in Figure 3.6 shows the grouping 
of samples based on their protein identity. While large separation was observed for those proteins 
producing a visually noticeable response (BSA, HSA, and IgG), even those solutions which were not 
appreciably different by eye (i.e. Fib, Lyz, Hgb) could be resolved using PCA classification (Figure 
3.6). 
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Figure 3.5 Absorption spectra for “chemical nose” solutions with 6 different protein samples at 
150 nM. A) Average absorption curves (n = 7 or 8) highlight differences between proteins. B) 
Contour plots of individual absorption curves (n = 7 or 8) highlighting similarity between 
replicates. 
 
 
Figure 3.6 Principal Component Analysis (PCA) biplot of “chemical nose” response to different 
proteins at 150 nM. Ellipses represent 95% mean confidence levels. 
40 
 
3.4.5 Protein Mixtures 
While the detection and quantification of single proteins is often useful in research environments, 
many samples may contain mixtures of proteins. In particular, clinical samples used for diagnostics will 
almost certainly contain a variety of different proteins and components. The “chemical nose” solution 
was combined with binary mixtures of HSA and IgG to determine whether their relative abundance 
affects the observed response. For each mixture, the total protein concentration was held constant at 150 
nM and the mole fraction of HSA was set to 75%, 50%, or 25%. These samples were also compared to 
the single protein solutions containing 150 nM HSA and 150 nM IgG. As is shown in the resulting PCA 
biplot (Figure 3.7), samples containing only HSA or IgG form two separate clusters, while mixtures fall 
in between the two. This suggests that the absorption spectra for binary mixtures of HSA and IgG 
contain features of both pure solutions. It is interesting to note that while the clusters for mixed samples 
fall between HSA and IgG, they are not evenly spaced as may be expected if both proteins were 
contributing equally to the response. In fact, 25% and 50% HSA lie closer to IgG than HSA, and 75% 
HSA falls near the midpoint between the two populations. This is likely due to the fact that 150 nM IgG 
has a stronger aggregating effect compared to 150 nM HSA (Figures 3.4 and 3.5). 
 
Figure 3.7 Principal Component Analysis (PCA) plot of “chemical nose” response to different 
mixtures of proteins. Composition reflects mole fraction of HSA in 150 nM total protein (HSA + 
IgG) concentration. Ellipses represent 95% mean confidence levels. 
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3.4.6 Complex Media 
The quantification of protein levels in complex media such as serum can be used to diagnose a 
multitude of diseases.
2,94,120
 Total protein and albumin/globulin ratio (AGR) are among the routine tests 
ordered by health care providers in determining a patient’s health status. In particular, low pretreatment 
AGR is often associated with increased mortality in cancer patients and may be a valuable predictor of 
therapeutic success.
121–124
 A serum IgG level greater than 1.5 times the upper normal limit is also one of 
the primary diagnostic criteria for autoimmune hepatitis
2. The “chemical nose” system could be trained 
to distinguish between samples containing various levels and ratios of protein commonly found in 
serum. To obtain serum samples with elevated globulins, normal adult male serum was diluted in 1/4X 
PBS containing human IgG. Normal serum was then diluted in the same volume of 1/4X PBS without 
IgG to serve as a baseline comparison. The concentrations of IgG chosen for elevated and baseline 
samples were based on average IgG levels in healthy adult males
126
 and represent an approximate two-
fold increase. Diluted serum samples containing elevated or baseline IgG levels were then mixed with 
the “chemical nose” solution. The resulting average absorption curves for 8 replicates are shown in 
Figure 3.8A. The vertical shift in curve position relative to the 1/4X PBS control indicates that overall 
absorbance was significantly higher, likely due to slight sample turbidity. However, when normalized 
against a baseline absorbance at 800 nm, a two-tailed t-test reveals that peak height for serum samples 
containing elevated IgG was significantly lower compared to the baseline serum sample (p<0.01). The 
PCA biplot in Figure 3.8B demonstrates the separation of both groups based on the features of their 
absorbance spectra. 
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Figure 3.8 A) Mean absorption spectra for “chemical nose” solutions with serum containing 
baseline and high IgG (n = 8). B) Principal Component Analysis (PCA) plot of “chemical nose” 
response to serum containing high and baseline IgG. Ellipses represent 95% mean confidence 
levels. The observed decrease in peak height between baseline and high IgG was statistically 
significant at p < 0.01. 
3.5 Conclusion 
We demonstrated that the differential effect of various proteins on gold nanoparticle absorption 
spectra can be used to detect, identify, and quantify proteins in aqueous solutions, mixtures, and 
complex media such as human serum. We also noted the effect of ionic strength on this response and 
optimized the conditions for detection of nanomolar protein concentrations. Variations in the 
concentration-dependent response between proteins suggest several regimes which can stabilize or 
aggregate gold nanoparticles without surface functionalization. Two different nanoparticle 
morphologies with different aggregation behaviours were combined in one “chemical nose” solution for 
increased discriminatory potential, as previously demonstrated only in bacteria. Using PCA, several 
different proteins could be distinguished at nanomolar levels based on variations in the absorbance 
spectra of gold nanoparticles following ambient incubation. Binary mixtures of these proteins were also 
distinguishable and showed trends related to the mole fraction abundance of each protein. Finally, we 
demonstrated a novel method of protein analysis in complex media by successfully distinguishing 
serum samples with and without elevated IgG levels. This technique can be further improved by 
including more nanoparticle morphologies, thereby increasing the variety of observable responses. 
Future investigations will also seek to characterize these aggregation behaviours to enhance detection 
capabilities for various research, clinical, and consumer-level applications.  
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Chapter 4 
Discrimination of proteins based on interactions with surfactant-
stabilized gold nanoparticles: Effects of surfactant type and 
concentration 
4.1 Summary 
Protein analysis is a fundamental aspect of biochemical research. Gold nanoparticles are an 
emerging platform for various biological applications given their high surface area, biocompatibility, 
and unique optical properties. The colorimetric properties of gold nanoparticles make them ideal for 
point-of-care diagnostics. Different aspects of gold nanoparticle-protein interactions have been 
investigated to predict the effect of protein adsorption on colloidal stability but the role of surfactants is 
often overlooked, despite their potential to alter both protein and nanoparticle properties. Herein, we 
present a method by which gold nanoparticles can be prepared in various surfactants and used for array-
based quantification and identification of proteins. The exchange of surfactant not only changed the 
zeta potential of those gold nanoparticles, but also drastically altered their aggregation response to five 
different proteins (bovine serum albumin, human serum albumin, immunoglobulin G, lysozyme, and 
hemoglobin) in a concentration dependent manner. Finally, we demonstrate that varying surfactant 
concentration can be used to control assay sensitivity. 
4.2 Introduction 
Gold nanoparticles are a common platform for emerging nanobiosensors due to their unique optical 
properties and functionalizability.
3,52,113
 Localized surface plasmon resonance of gold nanoparticles 
lends these solutions a variety of colours from orange-red to purple-blue, depending on particle size and 
shape.
57
 Particle aggregation causes plasmon coupling and the resulting shift in colour can be visible to 
the unaided eye.
116
 Several studies have shown how colloidal stability of gold nanoparticles can be 
controlled with functionalized aptamers, peptides, or antibodies to detect whole cells
132
, proteins
5
, 
nucleic acids
8
, and small molecules
133,134
. While these systems offer excellent specificity due to their 
“lock and key” design, high synthesis complexity and probe cost limit their usefulness for broad-
spectrum protein sensing. 
Proteins in solution can adsorb onto nanoparticles and induce changes in colloidal stability without 
the need for specific probes
51,90,135
. Particle size
68,69,71,136
, shape
14,40,72
, surface coating
51,83,88,90
, and 
charge
76,83
 are all thought to affect how these colloidal interactions, and the resultant effects on particle 
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aggregation. Single-nanoparticle systems for protein quantification have been demonstrated based on 
this phenomenon, where the adsorption of proteins to gold nanoparticles changes their colloidal 
stability.
9,10,79
 One group has even shown the ability to distinguish between different protein 
conformations.
11
 The advantages of these systems over probe-based systems are lower synthesis cost 
and the ability to detect a wide variety of proteins. By preparing an array of different nanoparticles 
which respond differently to the same analyte, a “chemical nose” type sensor could generate a unique 
fingerprint for each analyte.
119,129
 Compared to other multiplexed systems that use displacement of 
quenched green fluorescent protein (GFP)
117
, monitoring the absorbance spectrum and aggregation of 
gold nanoparticles does not require the use of expensive fluorophores or a fluorescence spectrometer. 
While many different aspects of gold colloid stability have been studied, the role of surfactants on 
protein-nanoparticle interactions is frequently overlooked. It is well known that surfactants can change 
nanoparticle surface properties and induce protein denaturation. Many ionic surfactants such as sodium 
dodecyl sulfate (SDS) and cetyltrimethylammonium bromide (CTAB) are strong denaturing agents.
137–
139
 Non-ionic surfactants such as Triton X and TWEEN
®
 20 (polysorbate 20) generally don’t denature 
proteins.
137,140
 The degree to which a protein is denatured depends on many factors including charge, 
hydrophobicity, and structure of the protein and surfactant.
137,141
 Protein denaturation can also affect 
protein-nanoparticle interactions by changing the number and nature of binding sites, whether they are 
hydrophobic regions, charged regions, or exposed thiol groups
11
. It is therefore likely that surfactant 
type can influence gold nanoparticle-protein interactions and govern their colloidal stability. To our 
knowledge, no study has leveraged these differences for protein detection and identification. In this 
investigation, we demonstrate how the use of different surfactants to stabilize gold nanoparticles can 
affect protein-induced aggregation. We also demonstrate how several different proteins can be visually 
distinguished at nanomolar concentrations based on their unique response to three different surfactant-
nanoparticle combinations. Finally, we show how varying the surfactant concentration can change the 
sensitivity across a range of protein concentrations, allowing for colorimetric assays with adjustable 
linear ranges. These findings have implications beyond the biosensor application, wherever the 
influence of biomolecules on gold nanoparticle stability may alter their behaviour. 
4.3 Materials and Methods 
4.3.1 Materials 
Gold (III) chloride hydrate (HAuCl4·xH2O), CTAB, sodium borohydride, silver nitrate, 
hydrochloric acid, nitric acid, sodium hydroxide, L-ascorbic acid, SDS, TWEEN
®
 20, bovine serum 
albumin (BSA)(A2153), albumin from human serum (HSA)(A1653), immunoglobulin G from human 
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serum (IgG)(I4506), human hemoglobin (Hgb)(H7379), and lysozyme from chicken egg white 
(Lyz)(L6876) were purchased from Sigma-Aldrich (Oakville, ON, Canada). Trisodium citrate dihydrate 
and BupH phosphate buffered saline packs were purchased from Thermo Fisher Scientific (Burlington, 
ON, Canada). Sterile UV-star 96-well microplates, scintillation vials (20 mL), sodium chloride (ACS 
grade), Nalgene sterilization filter units (0.2 µm pore size), 15 mL polypropylene centrifuge tubes, and 
1.7 mL polypropylene microcentrifuge tubes were purchase from VWR (Mississauga, ON, Canada). 
All procured chemicals were used without further purification. The 20 mL vials used for gold nanoseed 
synthesis were cleaned using 12M sodium hydroxide and larger glassware was cleaned using aqua regia 
as described in a previously published protocol.
125
 Water used for the preparation of solutions was 
purified using a Millipore water filtration system to an electrical resistivity greater than 15 MΩ∙cm. All 
other glass vials were triple-rinsed with Millipore water and dried completely prior to use. 
4.3.2 Gold nanoparticle synthesis 
Spherical CTAB-coated gold nanoparticles were synthesized according to a previously published 
protocol.
65
 All synthesis solutions were prepared in Millipore water (>15 MΩ∙cm). Briefly, gold seed 
precursor was prepared by adding 60 μL of ice-cold sodium borohydride to a solution containing 
18.812 mL of Millipore water, 188 μL of 10 mg/mL gold (III) chloride, and 1 mL of 2 mM trisodium 
citrate under vigorous stirring. Following addition of sodium borohydride, the solution was stirred for 1 
minute and left to mature overnight under dark ambient conditions. Nanoparticle growth solution 
(221.76 mL) was prepared under moderate stirring by adding 8.974 mL of 11 mM gold chloride, 1.344 
mL of 5 mM silver nitrate, and 1.442 mL of 100 mM L-ascorbic acid to 210 mL of 1.47 mM CTAB. 
Finally, 5.6 mL of gold seed precursor was added to the nanoparticle growth solution and stirred for an 
additional 1.5 minutes, at which point the solution was incubated overnight under dark ambient 
conditions. The final nanoparticle solution was pelleted via centrifugation (16000 RCF for 15 minutes) 
and resuspended in 1 mM CTAB solution.  
4.3.3 Surfactant exchange 
TWEEN
®
 20 and SDS-stabilized nanoparticles were prepared from CTAB stabilized nanoparticles 
by repeated washing and surfactant replacement. Parts of this procedure were adapted from Tebbe et 
al.
30
, wherein CTAB was displaced from gold nanoparticles by BSA. Here, gold nanoparticles 
suspended in 1 mM CTAB were added dropwise under ultrasonication to an equal volume of the new 
concentrated surfactant (100 mM TWEEN
®
 20 or 100 mM SDS). Solutions were then sonicated for an 
additional 2 minutes prior to centrifugation for 15 minutes at 10,000 RPM. The supernatant was 
discarded and the nanoparticle pellets were resuspended and sonicated in a 1 mM solution of the new 
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surfactant. This centrifugation and resuspension process was repeated twice, with the final resuspension 
being in half the supernatant volume to regain original particle concentration. Nanoparticles were then 
characterized and tested for stability in PBS. 
Gold nanoparticle solutions with different CTAB concentrations were prepared by centrifuging 
particles for 15 minutes at 10,000 RPM, discarding the supernatant, and resuspending the nanoparticles 
in a higher or lower concentration of CTAB. Since some residual solution remained after supernatant 
extraction, this wash step was repeated twice to bring the CTAB concentration as close as possible to 
the nominal value. 
4.3.4 Gold nanoparticle characterization 
Characterization of gold nanoparticles was performed using ultraviolet-visible (UV-Vis) 
spectroscopy, zeta potential, and dynamic light scattering (DLS) measurement. Absorbance spectra 
were collected from 300 nm to 900 nm, at 1 nm increments, on 300 μL samples in 96-well plates using 
an Epoch
TM
 Microplate Spectrophotometer (Winooski, VT, USA). Zeta potential and DLS 
measurements were performed concurrently using a Malvern Zetasizer
®
. Prior to DLS and zeta 
potential measurement, samples were diluted 1:2 in 1/4X PBS (pH 7.4) to match experimental ionic 
conditions. 
4.3.5 Preparation of protein solutions  
Fresh protein solutions were prepared prior to each experiment from lyophilized powder as per 
supplier’s instructions. Reconstitution was performed by weighing out the lyophilized powder in a 
microcentrifuge tube and adding the appropriate amount of sterile solvent (PBS or NaCl saline). Gentle 
inversion was used to promote protein dissolution and prevent denaturation from shear stress due to 
vortexing. Following reconstitution, protein concentrations were verified and adjusted as necessary 
based on A280 measurements. The Beer-Lambert Law (Eq. 3.1) was used to calculate molar 
concentrations from absorbance values using absorption parameters from the supplier (or literature 
where supplier values were not available) (Table 3.1). 
Serial dilutions were performed to achieve protein concentrations below the linear range of the 
Epoch
TM
 Microplate Spectrophotometer (0.1-2.0). Protein concentrations for samples outside this range 
were extrapolated from the closest dilution with a reliable absorbance value. To obtain a final 
concentration of 150 nM, solutions were first normalized using A280 to a concentration of 4.5 μM. 
Samples were then diluted 10X to achieve a concentration of 450 nM. Following addition of 200 μL of 
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gold nanoparticle solution to 100 μL of 450 nM protein solution, the final protein concentration was 
150 nM. 
4.3.6 Protein-gold incubation 
Concentration-dependent response and protein identification, experiments were assessed 
spectrophotometrically in a transparent 96-well plate. 100 μL of each protein sample or solvent control 
was added to the 96-well plate. 200 μL of the gold nanoparticle solution was then added to each well 
containing protein or control solution. Eight replicates were used for each protein-surfactant 
combination during protein discrimination at 150 nM. Plates were then placed on a Stovall Belly 
Dancer orbital shaker (Peosta, IA, USA) for 2 minutes prior to 20 hour incubation in the dark at room 
temperature. Following incubation, spectral scans for each well containing gold nanoparticles were 
obtained from 300-900 nm, in increments of 1 nm. 
4.3.7 Data analysis 
Normalized response was defined as a change in peak height relative to the solvent control. First, 
the position (in nanometers) of the control absorbance peak was determined. Absorbance values at that 
wavelength were then recorded for all samples. Baseline absorbance at 800 nm was then determined for 
each sample, including solvent controls. Peak height was calculated by subtracting the sample’s 
baseline absorbance (800 nm) from the sample’s absorbance corresponding to the control peak position 
(Eq. 3.2). Peak heights were then normalized against the control to obtain a normalized response for 
each protein sample (Eq. 3.3). 
Protein classification was done in R using the FactoMineR package for Multiple Factor Analysis 
(MFA).
142
 Each protein assayed consisted of 3 datasets (1 spectrum for each surfactant). Each spectrum 
was treated as a separate category in MFA. All figures were plotted using OriginPro. Photographs were 
taken using a Canon
 
EOS Rebel T3 digital camera. 
4.4 Results and Discussion 
4.4.1 Surfactant exchange 
We prepared three nanoparticle solutions, each with a different surfactant to study the surfactant’s 
effect on the colloidal stability of gold nanoparticles. The cationic surfactant CTAB was used to 
stabilize nanoparticles during their synthesis. A 1 mM surfactant concentration was chosen based on 
preliminary experiments since this value was close to the minimum concentration required to maintain 
colloidal stability in saline. TWEEN
®
 20 and SDS were chosen as model nonionic and anionic 
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surfactants respectively. A common strategy for displacement of CTAB takes advantage of strong thiol-
gold interactions.
143
 However, displacement by non-thiolated molecules is possible. It has recently been 
confirmed through surface-enhanced Raman spectroscopy (SERS) that complete displacement of 
CTAB by BSA on the surface of gold nanoparticles can be achieved without nanoparticle aggregation.
30
 
Using a similar strategy, dropwise addition of CTAB coated nanoparticles into high concentrations of 
TWEEN
®
 20 or SDS while under ultrasonication was found to produce stable nanoparticles with 
negligible changes in absorption spectra. When resuspended in 1 mM solutions of their respective 
surfactant, these solutions were also stable under moderate ionic conditions (addition of 100 μL 1/4X 
PBS to 200 μL nanoparticle solution). 
CTAB is a cationic surfactant due to its quaternary ammonium cation. As a result, CTAB-stabilized 
gold nanoparticles are cationic.
65
 Due to the nonionic and anionic nature of TWEEN
®
 20 and SDS 
respectively, nanoparticles coated with these surfactants should adopt neutral and negative zeta 
potentials at pH 7.4. The results of zeta potential measurements at pH 7.4 are shown in Table 4.1. 
Reversal of zeta potential from +25.7 mV for CTAB-stabilized particles to -46.5 mV for SDS-stabilized 
particles matches the predicted outcome based on surfactant charge. While nanoparticles stabilized with 
nonionic TWEEN
®
 20 still possessed an electrostatic potential of approximately -16.2 mV, the polarity 
was inverted compared to CTAB-stabilized particles and the magnitude of this potential was smaller 
than that of anionic SDS. Despite predictions of a neutral particle given to the anionic nature of 
TWEEN
®
 20, these results reflect other studies where zeta potential of TWEEN
®
 20 coated gold 
nanoparticles were studied.
144–146
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Table 4.1 Surfactant structures and zeta potentials of gold nanoparticles after being stabilized 
with 1 mM CTAB, 1 mM TWEEN
®
 20, or 1 mM SDS. Zeta potentials measured following 1:2 
dilution in 1/4X PBS (pH 7.4). 
Surfactant Structure Type NP Zeta 
Potential 
(pH 7.4) 
CTAB 
 
 
 
Cationic 25.7 mV 
TWEEN
®
 20 
 
 
 
Non-ionic -16.2 mV 
SDS 
 
 
 
Anionic -46.5 mV 
 
The process of surfactant exchange instead of de novo synthesis with different surfactants was 
chosen to preserve the size and morphology of the gold cores, as both these parameters can impact 
nanoparticles-protein interactions. DLS results indicate the average particle diameters were similar 
(Table 4.2). Slight variations were likely due to minor aggregation during the washing and 
centrifugation process. 
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Table 4.2 DLS measurements for gold nanoparticles suspended in CTAB, Tween
®
 20, or SDS. 
Values represent the mean of three consecutive measurements (± SD). 
Surfactant Mean diameter (nm) Polydispersity 
CTAB 34.3 (±0.7) 0.20 
TWEEN 
®
 33.1 (±0.5) 0.21 
SDS 32.5 (±0.5) 0.22 
 
This exchange of surfactant from one type to another is useful for nanoparticle characterization 
since it allows each nanoparticle variety to use the same gold core. While synthesis of similar 
nanoparticles can be achieved using different surfactants, maintaining inter-batch reproducibility while 
changing surfactant type would require extensive tuning and quality control or specialized purification. 
Using gold cores from a single process and replacing the surfactant post-synthesis helps control inter-
batch variability. This technique also allows nanoparticle morphologies synthesized in a non-
biocompatible surfactant to be adapted for use in vivo. It is interesting to note that gold nanoparticles 
with anionic side chains are generally considered less toxic than their cationic counterparts.
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Furthermore, nonionic surfactants and particularly the polyoxyethylene sorbitan family (i.e. TWEEN
®
) 
have lower skin toxicity than both cationic and anionic surfactants.
148
 As a result, a similar surfactant 
exchange strategy could be used to produce surfactant stabilized gold nanoparticles where CTAB 
toxicity is of concern. 
4.4.2 Protein identification 
Due to aggregation-dependent changes in colour, the effects of proteins on gold nanoparticle 
stability can be monitored visually or using a spectrophotometer. In some cases, addition of proteins has 
been shown to induce aggregation in a concentration-dependent response.
11,40,79
 Other studies have 
shown that addition of proteins can actually stabilize gold nanoparticles against harsh environments 
(e.g. high salt conditions).
22,30
 These observations are dependent upon many factors including particle 
size 
68,69,71,136
, shape 
14,40,72
, and charge 
76,83
. When multiple proteins are assessed, the observed changes 
in absorption spectrum are also dependent on the protein identity.
13,14
 
 To assess whether proteins can be discriminated based on their interaction with surfactants, we 
incubated five 150 nM protein solutions (BSA, HSA, Hgb, IgG, and Lyz) with each surfactant-
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nanoparticle combination and characterized their UV-Vis absorption spectra. Solutions were incubated 
overnight under dark ambient conditions to allow solutions ample time for colour change, however 
samples were noticeably different within 1 minute of incubation. The final appearance of each well is 
shown in Figure 4.1. In many cases, clear differences between the proteins were apparent. While the 
responses of BSA, Hgb, and PBS appeared similar to the unaided eye, they could be distinguished 
based on spectrophotometric data (Figure 4.2). Preliminary experiments in CTAB showed a 
concentration-dependent response to HSA and BSA from 27.46 nM to 450 μM. However, Lyz did not 
induce a response at any tested concentration. Unlike the response observed in CTAB, Lyz caused 
extensive colour shifts in TWEEN
®
 20 particles, whereas HSA and BSA did not. These changes in 
colour correspond to red-shifting and peak broadening in the absorption spectra (Figure 4.2A-C), and 
support the notion that the surfactant type plays a key role in modulating nanoparticle stability. 
 
Figure 4.1 Visual appearance of gold nanoparticles with different 1 mM surfactants after 20 hour 
incubation with 150 nM BSA, HSA, Hgb, IgG, Lyz, or ¼X PBS (negative control). 
Multiple factor analysis (MFA) was performed on the full set of UV-Vis absorption curves 
following the 20 hour incubation period. MFA was chosen since this extension of principal component 
analysis (PCA) allows each nanoparticle spectrum (CTAB, TWEEN
®
 20, and SDS) to be treated as 
distinct set of variables (i.e. separate features of the fingerprint). In this case, each surfactant-
nanoparticle combination was treated as a separate dataset with 48 samples (8 replicates x 5 proteins 
and 1 negative control). The data from IgG dilutions were also included, from 1200 nM to 9 nM, to 
highlight the effect of protein concentration. The resultant biplot is shown in Figure 4.2D. 
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Figure 4.2 Differential response of gold nanoparticles to five different proteins at 150 nM. 
Average UV-Vis absorption spectra (n=8) are shown for A) CTAB-stabilized nanoparticles, B) 
TWEEN
®
 20-stabilized nanoparticles, and C) SDS-stabilized nanoparticles. D) A multiple factor 
analysis (MFA) plot for the combined response of all three nanoparticles to each protein at 150 
nM is shown. A b-spline curve (green dash) is shown to help visualize the concentration gradient 
for IgG dilutions (IgG Dils) from 1200 nM to 9 nM. 
The MFA biplot of five proteins and one negative control shows grouping and separation of 
samples based on their protein identities. The largest separation was observed for HSA, IgG, and Lyz, 
as these proteins produced large spectral shifts in at least one surfactant-particle combination. Weaker 
responses for BSA and Hgb result in grouping closer to the control. However some clustering and 
separation is still evident. The two principal components identified using this method could account for 
90.34% of observed variability between samples. 
4.4.3 Protein concentration-dependent response 
IgG solutions were prepared at several concentrations to observe how protein concentration affects 
spectral response for the three surfactants. The resultant UV-Vis absorption curves are shown in Figure 
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4.3. As concentration increases from 9.4 nM to 37.5 nM, we see a decrease in absorbance for CTAB 
and TWEEN
®
 20-stabilized nanoparticles (Figure 4.3A-B). At higher concentrations (75 nM to 1200 
nM) absorbance of CTAB-stabilized particles increases but the peak remains broad. Similarly, 
TWEEN
®
 20-stabilized particles increase in absorbance slightly at higher concentrations, but maintain a 
relatively narrow peak. In neither cases is the original absorbance peak regained at high protein 
concentrations. For SDS-stabilized nanoparticles (Figure 4.3C), as IgG concentration increases from 9.4 
nM to 600 nM, we see an increase in absorbance, contrary to the trend for CTAB and TWEEN
®
 20. 
Absorbance then decreases slightly as IgG concentration increases from 600 nM to 1200 nM. Even at 
the lowest IgG concentration assayed, significant spectral shifts and broadening and were observed. The 
trends of increasing and decreasing absorbance as protein concentration changes reflects previous 
observations that nanoparticles can enter different regimes of stability depending on protein 
concentration
81
. 
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Figure 4.3 Changes in UV-Vis absorption curves of gold nanoparticles in response to different 
IgG concentrations. Nanoparticles were suspended in A) 1 mM CTAB, B) 1 mM Tween 20, and 
C) 1 mM SDS. Arrows indicate the trend in absorption following increases in protein 
concentration. In C), asterisk (*) indicates a decrease in absorbance as concentration increases 
from 600 nM to 1200 nM, contrary to the overall trend. 
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The spectra in Figure 4.3 were analysed using MFA and plotted alongside the 150 nM protein 
samples (Figure 4.2D). A b-spline curve is shown to help visualize the dilution order. The 150 nM 
sample agrees with previously collected replicates, indicating good reproducibility. Higher and lower 
dilutions of IgG indicate that the position of samples on the MFA plot relative to the PBS control is 
concentration-dependent. While a change in direction around 150 nM reflects the bell-shaped response, 
performing the assay in the linear range would allow for concurrent identification and quantification. 
Furthermore, noticeable spectral broadening of SDS-stabilized particles with 9.4 nM IgG suggests the 
potential for lower concentrations to induce changes as well, therefore the detection limit for certain 
proteins may be significantly lower than 9.4 nM. 
4.4.4 CTAB concentration 
Previous studies have shown that CTAB concentration affects the extent of BSA and HSA 
denaturation.
139,149
 Since BSA conformation affects the extent of nanoparticle aggregation
11
, it is 
evident that surfactant concentration should be investigated as a means of controlling the extent of 
nanoparticle aggregation, and may be useful for developing colorimetric assays. To assess how 
different concentrations of surfactant affect the protein concentration-dependent response of gold 
nanoparticles, we prepared CTAB-stabilized gold nanoparticles in seven different dilutions of CTAB 
ranging from 50 mM to 0.78 mM. Lower concentrations of CTAB were not used due to particle 
instability at working salt conditions. We used BSA and CTAB as models due to previous studies 
which characterized CTAB-dependent denaturation of BSA.
149
 The normalized sample response was 
defined as a peak-height difference between sample and control UV-Vis absorption spectra (Eq. 3.2 and 
3.3). The resultant concentration-dependent curves are shown in Figure 4.4. 
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Figure 4.4 Concentration-dependent response of gold nanoparticles to BSA when suspended in 
varying concentrations of CTAB. Normalized response is plotted against A-G) concentration of 
BSA in μM and B) the ratio of       to BSA. 
One observation which few papers investigating protein-gold nanoparticle interactions report is the 
bell-shaped response curve. As protein concentrations increase, it has been proposed that particles pass 
through several regimes of stability.
81
 At low concentrations, protein concentration is too low to induce 
nanoparticle aggregation. An increase in protein concentration induces large nanoparticle aggregates to 
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form. If nanoparticles are exposed instantaneously to sufficiently high protein concentrations, the 
surface becomes saturated with protein and a large protein corona provides steric stabilization, thereby 
preventing aggregation. This behaviour was only recently described with polystyrene.
81
 The work by 
Cukalevski et al. relates this response to the number of IgG molecules per polystyrene nanoparticle. 
While their nanoparticles were devoid of surfactant, it is clear from Figure 4.4 that this relationship is 
also sensitive to surfactant concentration. A general trend emerges in Figure 4.4A, whereby increasing 
CTAB concentrations shift the response curve towards higher protein concentrations. In other words, 
higher protein concentrations are required to induce aggregation under higher CTAB concentrations. In 
Figure 4.4B, we see that this relationship scales approximately by       to BSA. Ongoing studies are 
investigating whether this behaviour is due to competition at the gold surface between CTAB and BSA, 
or whether denaturation of BSA by CTAB is an important step in gold nanoparticle aggregation. 
However, both mechanisms may allow for tuning of sensitivity and linear range in a surfactant-based 
gold nanoparticle protein sensor. 
Another observation with little representation in literature is the dual-peak present in concentration-
dependent response curves. This may be related to different conformational states adopted by the 
proteins as well as their distribution and density on the nanoparticle surface, however this remains an 
area of ongoing investigation. 
4.5 Conclusion 
The effects of proteins on gold nanoparticle stability and resultant changes in absorption spectra are 
frequently studied for applications in biomolecular sensing. Using a simple washing procedure, we have 
prepared several stable gold nanoparticles in cationic, nonionic, and anionic solutions. This surfactant 
exchange procedure resulted in nanoparticles with varying zeta potential and maintained their stability 
under moderate ionic conditions. By incubating these gold nanoparticles with different proteins, we 
have shown how the identity and concentration of a surfactant can change the particle aggregation 
behaviour. We have also demonstrated how differences in response produce a unique colour and UV-
Vis absorption pattern for each protein allowing for rapid visual protein identification. The effects of 
surfactants on nanoparticle response to proteins can therefore be exploited for multiplexed protein 
assays. Finally, we have shown how surfactant-coated gold nanoparticles can be a tool for studying 
interactions between nanoparticles and other biomolecules. 
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Chapter 5 
Conclusions and Future Work 
5.1 Conclusions 
Over the course of this research project, we have successfully demonstrated and expanded on the 
use of gold nanoparticles for protein detection and identification. First, the concentration-dependent 
response of gold nanoparticle aggregation was characterized. Thanks to the optical properties of gold 
nanoparticles, this aggregation could be monitored by spectroscopy, or by visual observation. It was 
found that different proteins can induce aggregation of gold nanoparticles, without the need to employ 
specific probes such as antibodies or aptamers. Variation between proteins produced different 
concentration-response profiles which form the basis of protein identification and quantification. 
Furthermore, it was found that expanding the range of protein concentrations reveals multiple 
aggregation regimes, a key aspect for biosensing frequently overlooked by current literature. 
Where previous studies have highlighted the effect of nanoparticle shape and size on protein-
induced aggregation
14,68,69
, and others have employed different gold nanoparticle shapes to detect and 
identify whole cells
119
, we combine these concepts to develop a “chemical nose” sensor for proteins. 
The importance of shape was confirmed by monitoring aggregation of spherical and branched gold 
nanoparticles to an array of proteins. Here, each nanoparticle shape was found to produce different 
aggregation profiles and absorbance spectra when exposed to either BSA or IgG. By combining the 
response of both shapes to a single protein, we leverage those differences to improve identification. 
Furthermore, when two shapes are mixed in a single solution, a hybrid absorption spectrum is produced 
and the distinction between proteins is maintained. This allows for a simplified one-well procedure and 
reduces the sample volume needed to perform the assay. 
This shape-based “chemical nose” was used to detect proteins in binary mixtures, as well as human 
serum. For binary solutions, it was shown that mixtures of HSA and IgG could be distinguished based 
on the ratio of HSA to IgG in solution. The observation that protein mixtures generated a response in 
between both pure proteins, and that similarity was dependent on the concentration of each protein 
suggests that relative protein concentrations could be estimated for unknown samples. Human serum 
represents a highly complex medium of significant clinical importance. The number of proteins in 
serum presents considerable challenges for quantitative and qualitative analysis due to potential 
interfering factors. Despite this complication, the “chemical nose” system was able to distinguish 
between serum samples containing a normal and clinically elevated concentration of IgG. The 
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development of gold-nanoparticle “chemical nose” platforms for proteins could therefore expand their 
use from laboratory research to clinical diagnostics. 
Electrostatics play a key role in protein-nanoparticle interactions and aggregation. Additionally, it is 
well known that surfactants can affect protein structure and that protein structure may be related to 
nanoparticle aggregation
11
. To further expand on the “chemical nose” strategy, it is therefore useful to 
investigate new ways of increasing the difference in observed aggregation between proteins. To this 
end, spherical gold nanoparticles synthesized in the cationic surfactant CTAB were re-dispersed in non-
ionic (Tween
®
 20) and anionic (SDS) surfactants. This changed their surface charge (as measured by 
zeta potential) while maintaining their colloidal stability in the absence of proteins. 
Changing the stabilizing surfactant had a clear impact on the protein-induced aggregation profile of 
these particles. For instance, lysozyme did not induce any appreciable aggregation of CTAB-coated 
nanoparticles, while extensive aggregation of Tween
®
 20-coated nanoparticles was observed. When 
identifying proteins, good grouping and separation was achieve by assaying proteins against an array of 
different surfactant-stabilized gold nanoparticles. In this case, the three different nanoparticles each 
represent a separate input into the “chemical nose”. However the array can be expanded to include any 
number of nanoparticle configurations. In addition to providing unique responses for protein 
identification, this technique of surfactant replacement is also significant since it may be used to 
produce stable particles with less-toxic surfactants than the currently popular CTAB. Furthermore, 
increasing surfactant concentration was found to shift the concentration-response profile to higher or 
lower concentrations. This behaviour suggests that the sensitive range of such protein assays could be 
adjusted simply by changing the concentration of surfactant. 
5.2 Recommendations for future work 
There remain many different aspects of protein-nanoparticle interactions that can be studied using 
the previously described methods. New discoveries can then be incorporated into protein sensing 
platforms to improve sensitivity, and discrimination between proteins. 
Little is currently known about the role of surfactants on protein-gold nanoparticle interactions. 
Given the popularity of surfactants such as CTAB to synthesize shape-controlled gold nanoparticles, 
this topic should receive considerable attention since these results show that surfactant identity can 
drastically alter nanoparticle stability in the presence of proteins. 
60 
 
This research focused independently on the effects of shape and surfactant. However, a 
combination of nanoparticle shapes, sizes, and chemical coatings could further enhance the 
discrimination power of such assays. By generating a library of gold-nanoparticle configurations, a 
plethora of different responses can be obtained. Statistical efforts and machine-learning could then be 
applied to select the optimal combination for greatest assay performance. 
The modularity of these gold-nanoparticle biosensors is one of their key features. By varying the 
concentration of surfactant, an added level of modularity can be added to control the linear range of 
these sensors. Currently, the mechanism behind this effect is not well understood. Potential 
explanations include the stabilizing effect of surfactants on nanoparticles, and the denaturing effect of 
surfactants on proteins. A better understanding of this relationship will help in the design of adjustable 
sensors. 
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